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CHAPTER 1 
LITERATURE REVIEW 
 
Transition Period 
 
 The periparturient period has troubled the dairy industry for decades, as success or failure 
during this time has long-term impacts on multiple production parameters and profitability. This 
time is also referred to as the transition period, and is temporally defined as the three weeks 
prior, until three weeks after calving (Grummer, 1995; Drackely, 1999).  This is arguably the 
most important stage in the dairy cow’s lactation cycle due to the many metabolic disorders 
associated with it.  The greatest factor presumed to be contributing to these adverse health events 
is a reduction in feed intake during the last three weeks pre-partum, with the largest decrease 
observed in the final week (Grummer, 1995).  Post-parturition, the cow is unable to obtain 
enough dietary energy, and mobilizes body tissues in order to support milk production and 
maintenance costs and thus enters into negative energy balance (NEBAL; Moore et al., 2005).  In 
fact, dietary energy intake does not equal energy output (net energy of lactation and 
maintenance) until at least the 2nd or 3rd month of lactation (Figure 1; Grummer, 1995).  Most 
cows are in NEBAL due to this inadequate energy intake and the severity of the energetic 
imbalance is often associated with adverse health events (Bell, 1995).  
Understanding the biology of the transition period is vital for both animal well-being 
issues, and to ameliorate the large financial burden on the dairy industry.  Godden and colleagues 
(2003) reported that 25% of all culls occur within the first 60 days in milk due to periparturient 
period failure, which has obvious economic implications.  The estimated annual cost of fatty 
liver (a consequence of NEBAL) in the U.S. dairy industry is over $60 million annually (Bobe et 
al., 2004), and has undoubtedly increased in the last 8 years due to increased input costs.  In 
addition, a two-kilogram decrease in peak lactation results in a loss of 200-300 kg of milk yield 
!!
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2 
throughout an entire lactation (Wallace et al., 1996).  Furthermore, poor transitioning cows are a 
financial burden attributable to reduced reproduction, decreased milk quality, culling, and death 
loss.  
 
 
 
 
 
 
 
 
 
 
 
 
  
Figure 1.1:  Energy requirement (!), intake ("), and balance (Δ) of 
cows during transition period. Adapted from Grummer (1995). 
!
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Metabolic Adaptions 
The transition period is metabolically unique because of the pronounced energetic 
demand of copious milk production in a brief period.  The large decrease in feed intake prior to 
calving results in a NEBAL, and the cow consequently mobilizes body reserves to meet energy 
requirements.  This requires a dramatic shift in energy metabolism and nutrient partitioning 
involving aspects of both homeorhetic and homeostatic controls (Bauman and Currie, 1980). 
Adaptations to support fetal demands and lactation onset are regulated by altered gene 
expression resulting in endocrine changes and endocrine signaling which allows for a 
transformation in energy utilization and storage (Bell, 1995).  Insulin and growth hormone 
(somatotropin) concentrations exhibit an inverse relationship during transition period (Ingvartsen 
and Andersen, 2000).   
Since insulin is a potent anti-lipolytic signal, its decrease results in lower rates of 
adipocyte lipogenesis and allows for increased lipolysis.  Increased growth hormone also acts on 
adipocytes making them insulin resistant and more sensitive to lipolytic hormones, again 
favoring adipose tissue mobilization during NEBAL (Bauman and Currie, 1980; Ingvartsen and 
Andersen, 2000).  Another function of decreased insulin concentration and sensitivity is 
decreased glucose utilization by extra-mammary tissues (primarily skeletal muscle), which 
permits increased glucose uptake and use by the mammary gland to support lactogenesis.  The 
mammary gland may require up to 80% of total glucose turnover during maximum production, 
and rates of hepatic gluconeogenesis are amplified to a great extent during early lactation 
(Bauman and Currie; 1980).   
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Mobilization of adipose tissue results in increased circulating non-esterified fatty acid 
(NEFA) and glycerol.  These substrates can then be utilized as energy sources by extra-
mammary tissues, precursors for hepatic gluconeogenesis (glycerol), de novo lipogenesis in 
mammary gland, hepatic oxidation, and are ketone precursors (Figure 1.2; Bauman and Currie, 
1980; Ingvartsen and Andersen, 2000).  In addition, severe NEBAL and the associated marked 
adipose tissue mobilization are loosely correlated with metabolic health disorders (Drackley, 
1999).  
 
 
 
 
  
Body fat
NEFA
Fat
NEFA NEFA
TG
FatVLDL
Ketone 
Bodies
Milk 
Fat
Mammary 
Gland
CO2
Propionate
Liver
InsulinEpi
Mitochondrial 
Fuel use
GH
Nutrient Partitioning
Figure 1.2: Fates of mobilized fat from adipose tissue in the lactating 
dairy cow.  Adapted from Drackley (1999).!!
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Health Disorders 
The trend towards fewer cows (from a nation-wide perspective), producing greater 
quantities of milk appears to be continuing as genetic selection remains primarily based on yield 
(Powell et al., 2010).  However, the dairy industry must overcome metabolic disorders associated 
with the transition period to capitalize on increasingly superior genetics.  Unfortunately, despite 
focused research and scientific emphasis placed on the transition period over the last 30 years, 
the incidence of transition cow problems has not decreased (Drackely, 1999). 
 
Rumen Acidosis  
Rumen acidosis is not directly caused by NEBAL but is common during the transition 
period and may play a role in metabolic disorders.  Acidosis is characterized by a drop in ruminal 
pH for an extended period of time, and is detrimental to the balance of the rumen microflora 
(Plaizier et al., 2009).  This occurs primarily during the post-partum period in dairy cows due to 
a sudden change in diet.  It is common in the dairy industry to feed a high fiber, low concentrate 
diet during the dry period to avoid excess body fat accumulation (Goff and Horst, 1997; Kleen et 
al., 2003).  When switched to a higher starch diet (typical early lactation diet) rumen bacteria that 
metabolize starch to lactate respond quickly but those that utilize lactate respond slowly (Plaizier 
et al., 2009).  High lactate concentrations and reduced absorptive ability of the rumen lead to a 
decrease in pH.  It is important to note that the acidity of lactate is 10 times that of VFAs so its 
presence has a greater effect on rumen pH (Goff and Horst, 1997).  Once pH drops below a 
threshold level, many rumen microbes are killed or become inactive and release endotoxins 
(lipopolysaccharides [LPS]).  Normally, LPS is contained within the lumen of the GIT and do 
not represent a post-absorptive health problem (Andersen et al., 1994).  However, if the GIT 
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barrier is compromised, LPS can adversely affect a variety of immunological and metabolic 
systems (Bertoni et al., 2008; Plaizier et al., 2009, 2011, 2012). 
There are two ways LPS can translocate across the epithelium of the gastro-intestinal 
tract (GIT): transcellular (across the cell membrane) and/or paracellular (across tight junctions 
[TJ] between cells; Tomlinson and Blikslager, 2004).  Transcellular transport occurs mostly by 
active transport, while paracellular transport is limited due to the TJ proteins prohibiting passive 
movement of macromolecules (Plaizier et al., 2011).  However, during physiological (cold/heat, 
dietary modification, cytokines, microorganisms, antigens) and/or psychological stress (i.e. 
agitation) the integrity of TJ can be compromised, leading to increased epithelial permeability 
and thus LPS infiltration into circulation (Gareau et al., 2008).  In vitro studies have also 
demonstrated that the presence of LPS in the rumen may reduce barrier function of the rumen 
mucosa, but, because of differences in the structure of the rumen epithelium, it is uncertain if 
LPS can impair barrier function to the same degree as it can in the lower GIT (Plaizier et al., 
2011).  The infiltration of LPS can impair liver function, negatively impact other tissues, and 
elicit an immune response (Goff and Horst, 1997; Plaizier et al., 2009).  Most, if not all, 
transition cows experience mild to moderate cases of rumen acidosis (sub-acute ruminal 
acidosis) and on occasion some will experience clinical acidosis (Stone, 2004).  However, how 
LPS influences metabolism and transition cow performance has not been investigated. 
 
Fatty Liver and Ketosis 
Fatty liver (FL) is associated with the transition period due to severe adipose tissue 
mobilization.  Non-esterified fatty acids can be utilized as a fuel source by extra-mammary 
tissues (excluding brain), and this process “spares” glucose for mammary utilization. The liver 
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takes up excess NEFAs based on a concentration gradient (Bauman and Currie, 1980; Bobe et 
al., 2004).  There are several fates for NEFAs once they enter the liver.  After β-oxidation, the 
resulting acetyl-CoA can be oxidized in mitochondria via the tri-carboxylic acid (TCA) cycle or 
converted into ketone bodies.  Non-esterified fatty acids can also be oxidized by peroxisomes, or 
esterified into triglycerides (TG) and exported as very low-density lipoprotein (VLDL) or stored 
in liver (Drackely, 1999; Reynolds et al., 2003; Bobe et al., 2004).  Once the liver reaches the 
limit of what it can oxidize it begins to esterify excess NEFA to TG.  When the maximum 
capacity of liver export of VLDLs is reached the liver begins to accumulate TG thus leading to 
the development of fatty liver syndrome (Goff and Horst, 1997; Drackely, 1999; Bobe et al., 
2004; Mulligan and Doherty, 2008).  
Up to 50% of all cows have some degree of liver TG accumulation within the first four 
weeks post-partum (Grummer, 1993; Jorritsma et al., 2000, 2001).  The conversion of acetyl 
CoA to ketone bodies occurs due to a lack of oxaloacetate (which exits the TCA cycle to supply 
carbons for gluconeogenesis). Consequently, there is a reduced amount of oxaloacetate for acetyl 
CoA to react with and the excess acetyl CoA is converted into ketone bodies (acetoacetate and β-
hydroxybutyrate). This leads to increased levels of circulating ketones and can result in 
development of subclinical or clinical ketosis depending on the severity of mitochondrial 
dysfunction (Drackely, 1999; Bobe et al., 2004).  
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Zinc 
Role of zinc in biological systems 
Minerals are an important part of nutrition as deficiencies can decrease production and 
impair immune responses.  It is common practice in animal agriculture to supplement minerals in 
the diet to avoid deficiencies.  Zinc (Zn) is the second most abundant transition metal in living 
organisms behind iron (Vasak and Hasler, 2000).  It is also the only metal that is a cofactor in 
over 300 enzymes, including at least one enzyme from all six classes of enzymes (Rink and 
Gabriel, 2000; Ibs and Rink, 2003; Kambe et al., 2004; Rink and Haase, 2006).  Zinc plays three 
major biological roles in the organism (catalytic, structural, and regulatory), which includes cell 
growth, development, differentiation, homeostasis, connective tissue growth and maintenance, 
DNA synthesis, RNA transcription, cell division, cell activation and the immune system (Miller 
and Madsen, 1992; Dibley, 2001; Spears and Weiss, 2008; Chasapis et al., 2011).   Due to the 
fact that Zn is required during cell proliferation, deficiencies are often observed first in biological 
systems with high cell turnover rates (i.e. immune, intestinal, reproductive, and skin/hair; Rink 
and Gabriel, 2000).  
Both innate and adaptive immune responses require adequate Zn for proper function.  
Deficiencies in Zn lead to a reduction in lytic activity of natural killer cells, alter cytokine 
production in mast cells, impair immune signaling, impact the neuroendocrine immune pathway, 
and decrease T-cell proliferation and activation (Table 1.1; Rink and Gabriel, 2000, 2001; 
Chasapis et al., 2011; DeFrain et al., 2012). While deficiencies can have negative effects on the 
immune system, excessive levels of Zn can also have detrimental consequences, however the 
levels at which these negative effects are observed (in vitro) exceed in vivo Zn concentrations 
(Table 1.2; Rink and Gabriel, 2001; Ibs and Rink, 2003).  Interestingly, both immune cells and 
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pathogens can use Zn for proliferation, thus plasma Zn concentrations often decrease during the 
acute phase response to an infection (Ibs and Rink, 2003).  Zinc is also involved with the 
antioxidant system as a component of copper-zinc superoxide dismutase, which acts to remove 
reactive oxygen species that can damage cells (Spears and Weiss, 2008; Chasapis et al., 2011; 
DeFrain et al., 2012).   
 Although Zn is extremely important in all living organisms, there is no specialized 
storage system for it in the body; subsequently, daily Zn intake is required to reach a steady state 
(King et al., 2000; Rink and Gabriel, 2000).  Zinc, unlike iron (which is mainly bound to 
hemoglobin), is found throughout the body in all tissues with the majority located in muscle and 
bone (Rink and Gabriel, 2000; Chasapis et al., 2011).  In serum, Zn is predominately bound to 
albumin (60%, low affinity), α2-macroglobin (30%, high affinity), and transferrin (10%; Scott 
and Bradwell, 1983).  While the plasma pool is quantitatively minor, it is highly mobile and 
immunologically important (Rink and Gabriel, 2000; Ibs and Rink, 2003). 
 
   
Table 1.1: Immune functions decreased by zinc deficiency 
Peripheral T-cell count 
T-cell proliferation in response to PHA 
Thymocyte count in thymus 
Delayed-type hypersensitivity reaction 
T-helper cell function 
Cytotoxic T-cell activity 
NK cell activity 
Macrophage functions (phagocytosis, intracellular killing activity) 
Neutrophil functions (chemotaxis, oxidative burst) 
Serum thymulin level 
PHA, phytohaemagglutinin; NK, natural killer. 
Adapted from Rink and Gabriel (2000). 
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 Zinc Homeostasis 
  The regulation of Zn homeostasis occurs primarily via intestinal absorption and 
endogenous excretion in the GIT (King et al., 2000; Kambe et al., 2004).  Miller and Cragle 
(1964) demonstrated that Zn absorption occurs primarily in the small intestine of ruminants and 
increases as dry matter digestibility increases, illustrating some relationship between Zn and 
undigested feed particles.  There is also a difference in the total percent of dietary Zn absorbed 
and retained in the body depending on age, with an increase observed in younger versus older 
animals (Miller and Cragle, 1964).  Zinc is homeostatically regulated; therefore, Zn content in 
the whole body remains relatively constant in healthy animals even with varying levels of dietary 
Zn intake.   
Dietary Zn is absorbed into the intestinal epithelium from its apical side, then transferred 
via an unknown intracellular pathway to the basolateral side, and then released into portal 
Table 1.2: Relationship between zinc and immune cells in humans 
Cell Type Zinc deficiency Normal zinc level High zinc dosage 
Monocytes/macrophages Decreased functions Normal 
> 30 µmol/L: normal 
> 100 µmol/L: direct 
activation 
Neutrophil granulocytes Decreased phagocytosis Normal 
> 100 µmol/L: normal 
> 500 µmol/L: direct 
chemotactic activity 
Natural killer cells Decreased cytotoxicity Normal Suppressed killing 
T cells 
Decreased 
normal functions, 
increased auto-
reactivity and 
allo-reactivity 
Normal  
> 30 µmol/L: functions 
decreased 
> 100 µmol/L: functions 
suppressed  
B cells Apoptosis Normal Apoptosis 
Adapted from Ibs and Rink (2003). 
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circulation (Kambe et al., 2004).  As dietary Zn levels increase, GIT absorption rate declines and 
endogenous excretion increases; however, overall Zn balance is increased (King, 2000; Spears, 
2003).  Zinc homeostasis at the cellular level occurs via two primary metal transporter families: 
ZIP (ZRT, IRT-like protein) and cation diffusion facilitator (CDF; Kambe et al., 2004).  ZIP-
family transporters are involved with Zn influx into the cytosol from outside the cell or from the 
lumen of intracellular compartments and are thought to have eight trans-membrane domains 
(Guerinot, 2000; Kambe et al., 2003).  While CDF transporters allow for Zn efflux from cytosol 
to the outside of the cell and transport cytosolic Zn to intracellular organelles; this transporter is 
believed to have six trans-membrane domains (Kambe et al., 2004; Haney et al., 2005).   
Once inside the cell, Zn is available for four intracellular pools: 1) tightly bound to 
metalloproteins as structural component or cofactor; 2) bound to metallothioneins with a low 
affinity, which may provide an important labile pool acting as a reservoir and buffer of cytosolic 
Zn; 3) compartmentalization into organelles, may contribute to storage and/or detoxification; 4) 
exist as free Zn ions, however this is estimated well below nanomolar level (Figure 1.3; Kambe 
et al., 2004). 
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Figure 1.3:!Zinc in mammalian cells exists in four distinct pools. The transport of Zn into or out 
of cytoplasm is directed by two zinc transporter families, the ZIP family and the CDF family. (A) 
Zinc is tightly bound to metalloproteins as a structural component or as a cofactor; (B) loosely 
bound to MTs; (C) Zinc is compartmentalized in intracellular organelles; (D) The free zinc 
concentration in the cytosol (estimated to be well below a nanomolar level).  Adapted from 
Kambe et al. (2004).  
 
Zinc Supplementation/Bioavailability 
The NRC (2001) recommendation for fresh cows producing 35 kg of milk per day is 73 
mg of Zn/kg of DMI.   As with other minerals, there are varying sources of Zn commercially 
available that can be added to diets to ensure requirements are met.  The most common 
supplemented forms are Zn sulfate or oxide; however, there has been a growing use of “organic” 
forms of supplemental Zn (Spears, 1996).  The Association of American Feed Control Officials 
(AAFCO) defined four classifications of organic minerals: 1) metal amino acid (AA) complex- 
soluble metal salt complexed with an AA (s), 2) metal AA chelate- reaction of a metal ion from a 
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soluble metal salt with AAs at a mole to mole ratio of 1 metal ion to 1-3 moles of AAs forming a 
covalent bond, 3) metal proteinate- a product resulting from chelation of a soluble metal salt with 
AA and/or partially hydrolyzed protein, 4) metal polysaccharide complex- a product resulting 
from complexing a soluble salt with a polysaccharide solution (AAFCO, 2000).   
Bioavailability of Zn is determined by many factors including: animal’s age, gender, 
physiological function (i.e. growth, maintenance, and reproduction), environmental stress, 
nutritional/health status, interference by other minerals, form (i.e. organic vs. inorganic), 
interactions with naturally occurring ligands, and interactions at/across intestinal lumen 
(Ashmead, 1991).  Recent research suggests organic trace minerals (OTM) are more bioavailable 
since they are bound to AA, proteins, or polysaccharides, making them more stable within the 
GIT, consequently protecting them from binding to other dietary components, which could 
inhibit absorption (Ashmead, 1991; Spears, 1996).  However, results in the literature on the 
effects of level and form of supplemental Zn have been conflicting (Cope et al., 2009).  Wright 
and colleagues (2008) demonstrated an increased uptake of Zn proteinate compared to Zn sulfate 
in sheep GIT epithelial tissue.  Another ovine study reported a 10% increase in intestinal 
absorption, increased liver Zn levels, and up regulation of Cu/Zn-SOD activity in ewes fed 
Cu/Zn-methionine vs. Cu/Zn-sulfate (Pal et al., 2010).  In a recent dairy cow trial, no differences 
were observed in reproduction, health, or feed intake parameters, however an increased milk 
yield was reported in cows fed an organic Zn supplement during mid-lactation (Hackbart et al., 
2010).  Cope and colleagues (2009) showed no difference in feed intake, but increased milk 
production in cows fed OZn vs. Zn oxide (at NRC [2001] recommended levels), and a decrease 
in SCC and milk amyloid A concentrations in cows fed recommended Zn level vs. cows fed 
below NRC (2001) Zn recommendations, regardless of source.  Another study reported 
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tendencies for an increase in milk yield and energy corrected milk yield, and improvement in 
claw health when sulfate minerals were replaced with organic minerals (Siciliano-Jones et al., 
2008).  DeFrain and colleagues (2009) showed no differences in milk yield or claw health, but 
did see tendencies for lower milk SCC and an improvement in reproductive performance in cows 
fed OTM (including OZn).  Another dairy trial observed increased milk yield, decreased days 
open, and a tendency of increased first service conception rates, percent of cows pregnant at 150 
DIM, and decreased claw disorders at 75 DIM in cows fed OTM (Ballantine et al., 2002).  In a 
12 trial summary, Kellogg and colleagues (2004) reported improvements in lactation 
performance and production of milk components and reduced milk SCC in cows fed OZn (Table 
1.3 and 1.4).  They also indicated that OZn supplementation has positive effects on claw integrity 
under varying management, nutritional, housing, and environmental conditions (Kellogg et al., 
2004). 
 
 
 
Table 1.3: Effect of supplementing lactating dairy diets with 180 to 400 mg Zn/d per 
head of zinc methionine (ZM) complex. 
Item na Control ZM SEM P 
Milk, kg/d 10 30.5 31.8 1.6 <0.01 
 ECMb, kg/d 10 30.4 31.7 1.5 <0.01 
 3.5% FCMc, kg/d 10 30.0 31.6 1.5 <0.01 
 Fat, kg/d 10     1.06     1.10   0.05       <0.05 
 Protein, kg/d 10     0.96     0.99   0.05 <0.01 
 Fat, % 10     3.47     3.48   0.12         0.90 
 Protein, % 10     3.14     3.11   0.02         0.17 
 SCCd, x103/mL 10      294      196       41 <0.01 
aNumber of trials in which parameter was measured 
bECM = Energy-corrected milk (3.5% fat; 3.2% protein) 
 cFCM = Fat-corrected milk (3.5% fat) 
dSCC = Somatic cell count 
Adapted from Kellog et al., 2004 
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 Association Of NEFA And BHBA With Metabolic Disorders 
 There have been many studies investigating the causes and/or relationship of metabolic 
disorders with blood metabolites.  The current dogma is that the severity of NEBAL (thus the 
extent of adipose triglyceride lipolysis), and plasma concentrations of NEFA and BHBA are 
predictors of success or failure in transition cows (Drackely, 1999).  Research has illustrated 
associations between NEFA and BHBA with health disorders and reproductive performance.  
However, the associations are relatively weak and only explain a small amount of the variation 
observed in transition cow performance (Drackley et al. 2005). 
In some recent papers, the authors developed an optimum threshold based on highest 
combined sensitivity and specificity (LeBlanc et al., 2005; Duffield et al., 2009; Ospina et al., 
2010a).  This was used to group cows into higher or lower risk groups.  It is important to note 
that threshold levels varied between studies and week of lactation and depending upon which 
variable the metabolite was trying to predict.  Associations between elevated plasma NEFA and 
Table 1.4: Effect of supplementing lactating dairy diets with ≥360 mg zinc from zinc 
methionine (ZM) complex. 
Item na Control ZM SEM P 
Milk, kg/d 5 31.2 32.4 2.4 <0.01 
 
 
ECMb, kg/d 5 31.0 32.0 1.9 <0.05 
3.5% FCMc, kg/d 5 30.3 31.7 1.9 0.11 
Fat, kg/d 5 1.07 1.09 0.08 0.26 
 Protein, kg/d 5 0.98 1.01 0.07 0.05 
 Fat, % 5 3.45 3.41 0.23 0.51 
 Protein, % 5 3.15 3.12 0.03 0.35 
 SCCd, x103/mL 5 298 171 70 <0.01 
aNumber of trials in which parameter was measured 
bECM = Energy-corrected milk (3.5% fat; 3.2% protein) 
 cFCM = Fat-corrected milk (3.5% fat) 
dSCC = Somatic cell count 
Adapted from Kellog et al., 2004 
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BHBA concentrations, pre- or post-partum, to increased risk of developing retained placenta 
(RP), metritis, displaced abomasum or clinical ketosis (CK) have been observed in studies 
involving large numbers of cows (Tables 1.5 and 1.6; LeBlanc et al., 2005; Duffield et al., 2009; 
Ospina et al., 2010a, 2010c; Chapinal et al., 2011; Huzzey et al. 2011; Seifi et al. 2011).  Ospina 
and co-workers (2010b) evaluated reproductive performance and concluded that NEFA 
concentrations ≥ 0.27 and ≥ 0.72 mEq/L (pre and post-partum respectively) resulted in decreased 
risk of pregnancy (19 and 16%, respectively).  Similarly, Walsh and colleagues (2007) 
determined that cows with serum BHBA concentrations ≥ 1000 or ≥ 1400 µmol/L in the first or 
second week post-partum, respectively, were 20% less likely to become pregnant after first 
insemination.  In addition, Seifi and colleagues (2011) reported that cows with serum NEFA 
concentrations ≥ 1.0 mEq!/L in the first week postpartum were 3.6 times more likely to be culled 
within the first 60 days of lactation.  Chapinal and associates (2012) conducted a large field 
study and determined that in the week prior to calving, NEFA and BHBA (≥ 0.5 mEq/L and ≥ 
600 µmol/L respectively) levels were associated with 1.6 to 3.2 kg/d milk loss in the first 120 
days of lactation.  They also reported that NEFA and BHBA (≥ 0.7 mEq/L and ≥ 1,400 µmol/L 
respectively) concentrations within the first week after calving were only associated with 1.8 to 
2.4 kg/d milk loss in the first 30 days of lactation.  Interestingly, they found no association 
between NEFA or BHBA levels with reproduction parameters and also noted that lower NEFA 
and BHBA concentrations in the first 21 days in milk were associated with milk loss in the first 
120 days in milk.  This indicates that lipid mobilization in early lactation is important in attaining 
high levels of production (Chapinal et al., 2012). 
 While associations between health events and NEBAL have been illustrated, it is 
apparent that all cows exhibit elevated NEFA and BHBA concentrations to some extent but only 
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a small percentage of cows develop a metabolic disease.  This raises some doubt as to the causes 
of metabolic health events and poor production, and begs the question of whether there are other 
factors involved in initiating a cascade of events leading to transition failure.  
 
 
 
  
Table 1.5: Association of NEFA with metabolic disorders during transition period. 
Trial At/Above Threshold (%) 
Type of 
Analysis 
NEFA 
Threshold Results Time Point 
1 26 Odds Ratio ≥ 0.5 (mEq/L) 2.9 Inc risk Prepartum 
1 21 Odds Ratio ≥ 1.0 (mEq/L) 4.3 Inc risk Postpartum 
2 - Odds Ratio Per 0.15 
mmol/L inc 
2.04 Inc risk Prepartum 
3 36.6 Odds Ratio ≥ 1.0 (mEq/L) 11.3 Inc risk Postpartum 
4 - Risk Ratio ≥ 0.29 (mEq/L) 1.8 Inc risk Prepartum 
4 - Risk Ratio ≥ 0.57 (mEq/L) 4.4 Inc risk Postpartum 
5 19 Odds Ratio ≥ 0.5 (mEq/L) 4.1 Inc risk Prepartm 
5 23.1 Odds Ratio ≥ 1.0 (mEq/L) 4.8 Inc risk Postpartum 
Prepartum: within 14 d before calving  1. Chapinal et al., 2011 
2. Huzzey et al., 2011 
3. Seifi et al., 2011 
4. Ospina et al., 2010a 
5. Leblanc et al., 2005 
Postpartum: within 14 d after calving 
Metabolic disorder: classified as displaced 
abomasum, retained placenta, ketosis, or 
any combination. 
Table 1.6: Association of BHBA with metabolic disorders during transition period. 
Trial At/Above Threshold (%) 
Type of 
Analysis 
BHBA 
Threshold Results Time Point 
1   8 Odds Ratio ≥   800 (µmol/L) 3.7 Inc risk Prepartum 
1 32 Odds Ratio ≥   900 (µmol/L) 2.9 Inc risk Postpartum 
2    19.7 Odds Ratio ≥ 1200 (µmol/L) 8.5 Inc risk Postpartum 
3 - Risk Ratio  ≥     10 (mg/dL) 4.4 Inc risk Postpartum 
4     24.6 Odds Ratio ≥ 1200 (µmol/L) 3.35 Inc risk Postpartum 
5     19.9 Odds Ratio ≥ 1200 (µmol/L) 8.0 Inc risk Postpartum 
Prepartum: within 14 d before calving  1. Chapinal et al., 2011 
2. Seifi et al., 2011 
3. Ospina et al., 2010a 
4. Duffield et al., 2009 
5. Leblanc et al., 2005 
 
Postpartum: within 14 d after calving 
Metabolic disorder: classified as displaced 
abomasum, retained placenta, ketosis, or 
any combination. 
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Endotoxin And Transition Cow Disorders 
The possibility that a factor other than NEFA or BHBA is responsible for the negative 
effects during the transition period may offer new insights into better prediction and prevention 
of periparturient health disorders.  There are a variety of human intestinal integrity disorders 
(Crohn’s disease, irritable bowel syndrome, alcoholism, etc.) that result in post-absorptive 
changes that share some resemblance with the metabolic profile of ketotic cows.  Two key 
similarities are increased circulating NEFA and fatty liver (Feingold et al., 1992; Werling et al., 
1996; Parlesak et al., 2000; Bertoni et al., 2008; Miele et al., 2009; Gäbele et al., 2011).  As a 
consequence, we hypothesize that leaky GIT in some transitioning dairy cows may predispose 
them to developing fatty liver and eventually ketosis.   
Rumen acidosis is common during the transition period and is correlated with increased 
concentrations of LPS in ruminal fluid, which can then be released into the blood (whether the 
LPS enters the body via the rumen or in the lower gut is not clear; Plaizier et al., 2009, 2011, 
2012). In addition, inflammatory cytokines can compromise the integrity of the GIT (Murch et 
al., 1993) and it is suspected that uterine-derived inflammatory cytokines (a result of uterine 
injury during parturition) may negatively influence GIT barrier function.  Once LPS has 
infiltrated the GIT, it can elicit an immune response and we hypothesize that the intensity of the 
response contributes to periparturient failure. 
The liver holds a central role in clearing blood toxins and in responding to inflammatory 
conditions (i.e. LPS infiltration) with a general, non-specific response called the acute phase 
response (APR; Werling, 1996; Ametaj et al., 2005; Bertoni et al., 2008).  An APR is initiated by 
the release of cytokines by immune cells and is accompanied by a decrease in feed intake, 
changes in nutrient metabolism, and decreases in production (Kushibiki et al., 2003; Waldron et 
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al., 2003).  The biological actions of LPS-induced APR are primarily triggered by 
monocytes/macrophages release of pro-inflammatory cytokines such as tumor necrosis factor-α 
(TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β; Kushibiki et al., 2003; Ametaj et al., 
2005).  Cytokines stimulate production of APR proteins by hepatocytes and include serum 
amyloid A (SAA), haptoglobin (Hp), and LPS binding protein (LBP; Ametaj et al., 2005; 
Plaizier et al., 2012).  The role of LBP is to bind LPS and shuttle it to immune effector cells 
containing CD14 and TLR4 receptors (Opal et al., 1999).  Of the cytokines released, TNF-α may 
play a substantial role in reducing feed intake, which subsequently alters hepatic carbohydrate 
metabolism that results in less acetyl CoA entering into the TCA cycle (Kushibiki et al., 2003; 
Waldron et al., 2003; Amentaj et al. 2005).  The reduced feed intake would contribute to the 
NEBAL (increasing severity in the transition cow) and increase mobilization of adipose tissue 
and subsequent fatty liver syndrome (Werling, 1996; Kushibiki et al., 2003; Waldron et al., 
2003; Amentaj et al. 2005; Baurhoo et al., 2012).  There is also evidence that TNF-α causes 
increased hepatic NEFA esterification to TG and decreased VLDL secretion and both could 
certainly contribute to FL (Feingold et al., 1992). 
Another possible mechanism for an APR-induced fatty liver is insulin resistance.  Recent 
evidence in humans indicates insulin may block the action of pro-inflammatory cytokines that 
normally induce the APR, ergo a reduction in insulin action (a well known homeorhetic 
adaptation that occurs during the periparturient period [Bauman and Currier, 1980]) would allow 
for a prolonged or magnified APR and further increase the likelihood of developing fatty liver 
syndrome (Buigianesi et al., 2004).  Furthermore, insulin resistance up regulates lipogenic 
transcription factors favoring hepatic TG accumulation, while decreasing hepatic VLDL 
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secretion, thus leading to the accumulation of TG in the liver (Bugianesi et al., 2004; Adams and 
Angulo, 2005; Paquot and Delwaide, 2005; Tessari et al., 2009).  
Our lab group has recently demonstrated that cows that develop ketosis in early lactation 
have much higher (21%) levels of LBP and this difference was most pronounced (> 2 fold) on 3 
DIM compared to cows that were not diagnosed with clinical ketosis (unpublished data). This 
illustrates that LPS may cause transition disorders or at least may predict transition success. 
Plasma NEFA and BHBA were not strongly correlated with transition success parameters.  
While there were elevated BHBA on day 10 for poor transition cows this could be due to the 
development of ketosis secondary to LPS impairment of NEFA metabolism by hepatocytes.  Our 
theory is that elevated LPS could predispose cows to develop fatty liver, possibly leading to 
clinical ketosis and poor reproduction.  
 
  
!!
21 
21 
Summary And Thesis Objectives 
The transition period is an extremely critical time for a cow and can influence production 
capacity throughout the remainder of lactation.  There is a large metabolic shift associated with 
this period due to an inadequate energy balance, which initiates body tissue mobilization to meet 
energetic needs.  An increase in health disorders is also observed during this time due to the large 
metabolic shift; as well as an impaired or compromised immune system, which may be triggered 
by the stressors associated with calving, diet changes, and/or onset of lactation.  The immune 
system can be aided by supplying adequate levels of trace minerals due to their role in cell 
proliferation, especially in biological systems with a high cell turnover rate (i.e. immune, GIT, 
mammary).  There are two classes of trace minerals available (organic and inorganic) and 
research has illustrated benefits of incorporating OTM.  However, the results have been variable 
and may be difficult to compare due to differences in individual farm management and specific 
type of OTM provided.  Nevertheless, the importance of trace minerals in livestock production is 
evident and more investigation into the source of those minerals is warranted. 
 The objectives of this thesis are to determine the effects of increasing levels of 
supplemental OZn on metabolism, production parameters, and overall health in Holstein cows 
throughout the course of an entire lactation.  
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CHAPTER 2 
TRANSITION PERFORMANCE AND METABOLIC VARIABLES IN 
PERIPARTURIENT HOLSTEIN COWS FED INCREASING AMOUNTS OF ORGANIC 
ZINC 
 
Abstract 
Multiparous (n = 79) and primiparous (n = 68) Holstein cows were blocked by 305 
previous mature equivalent milk yield and parity and assigned to one of three dietary treatments.  
Treatments differed in Zn content as follows: 1) 75 mg/kg of DM supplemental Zn provided 
entirely as Zn sulfate (CON); 2) 33.3 mg and 15.5 mg of Zn sulfate/kg of DM in the control 
close up and lactation diets respectively were replaced by a Zn amino acid complex (Availa®Zn; 
MED); and 3) 66.6 mg and 40 mg of Zn sulfate/kg of DM in the control close up and lactation 
diets were replaced by a Zn amino acid complex (Availa®Zn; HIGH).  Cows were housed at the 
Iowa State University Dairy farm, and were individually offered a TMR containing dietary 
treatments beginning at 28 ± 15 d prior to expected calving date and continued until 250 DIM.  
Compared to controls, multiparous cows (but not heifers) fed OZn had increased (20%) 
colostrum IgG.  Feeding increasing levels of OZn did not affect prepartum DMI, but compared 
to CON-fed cows decreased (P < 0.01) DMI during lactation (5.1 and 3.2 %, respectively).  
Feeding increasing levels of OZn improved (P < 0.01) services per conception (38 and 24 %, 
respectively), and tended (P = 0.08) to increase NEFA concentration (455 vs. 409 µEq/L).  Feed 
efficiency measured as MY/DMI, FCM/DMI, and SCM/DMI increased (P < 0.05) 6.2, 5.8, and 
5.9 % in HIGH OZn vs. CON-fed cows.  MED-fed cows had reduced overall milk fat content 
(3.0%) compared to CON and HIGH-fed cows.  Cows fed HIGH OZn had increased (P < 0.01) 
SCC compared to the CON and MED-fed cows (35%), but less (P < 0.05; 17%) LnSCC than 
CON-fed cows.  Feeding increasing levels of OZn reduced feed intake without affecting overall 
milk production and therefore improved feed efficiency. 
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Introduction 
Early lactation cows are typically unable to consume adequate dietary energy to meet 
requirements for milk production and maintenance, and consequently enter into a state of 
calculated negative energy balance (NEBAL).  In transition cows the severity of NEBAL is 
thought to be associated with suppression of the immune system (Goff, 2006).  Trace minerals 
(including Zn) play a key role in immune function (Rink and Gabriel, 2000; Ibs and Rink, 2003) 
and research has demonstrated beneficial effects of supplementing organic trace minerals (OTM) 
in lactating dairy cattle.  For example, supplementing OTM reduces SCC, increases milk 
production, improves reproductive performance, and claw health (Uchida et al., 2001; Kellog et 
al., 2004; Nocek et al., 2006; Siciliano-Jones et al., 2008).  
 Of all the minerals, Zn plays a particularly key role in immune function due to its 
participation in cell proliferation.  Studies in humans and animals have demonstrated decreased 
natural killer cell activity (Fernandes, 1979; Allen et al., 1983), and inhibited B-lymphocyte 
antibody response during Zn deficiency (Luecke et al., 1978; DePasquale-Jardieu et al., 1984). A 
study utilizing Zn-deficient mice cells showed impairment of monocyte function in vitro, and 
this was rapidly reversed by adding Zn to the diet (Wirth et al., 1989).  Furthermore, Zn-deficient 
animals exhibit increased spontaneous and toxin-induced apoptosis in multiple cell types 
(Dinsdale and Williams, 1977; Zalewski and Forbes, 1993).  Additionally, in human subjects, Zn 
supplementation has been identified as a powerful immune system stimulant, with efficacy 
dependent upon dose (Fraker et al., 2000). 
 A number of studies have demonstrated the benefits of feeding OTM in lactating dairy 
cattle (Ballantine et al., 2002; Nocek et al., 2006; Siciliano-Jones et al., 2008; DeFrain et al., 
2009; Hackbart et al., 2010) however, few studies have specifically examined the effects of OZn 
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supplementation (Kellog et al., 2004; Cope et al., 2009).  Therefore, study objectives were to 
investigate the effects of OZn supplementation on metabolic variables, production parameters, 
reproductive indices, and health status in lactating Holstein cows.  
 
Materials And Methods 
 The Iowa State University Institutional Animal Care and Use Committee approved all 
procedures involving animals (#1-10-6863-B).  Multiparous (n = 79) and primiparous (n = 68) 
Holstein cows were blocked by previous 305 mature equivalent milk yield and parity, and then 
assigned to one of three dietary Zn treatments beginning 28 ± 15 d prior to expected calving date 
and continued until 250 DIM (Figure 2.1 and Table 2.1).  Treatments were (Table 2.2): 1) 75 
mg/kg of DM supplemental Zn provided entirely as Zn sulfate (CON), 2) control diet with 33.3 
(close up) and 15.5 (lactating) mg of Zn sulfate/kg of DM replaced by a Zn amino acid complex 
(MED; Availa®Zn; Zinpro Corporation, Eden Prairie, MN), and 3) control diet with 66.6 (close 
up) and 40.0 (lactating) mg of Zn sulfate/kg of DM replaced by Zn amino acid complex (HIGH; 
Availa®Zn; Zinpro Corporation, Eden Prairie, MN).  Manganese and copper were provided as a 
mixture of sulfate and organic sources (Zinpro®; Zinpro Corporation, Eden Prairie, MN).  
Cobalt was provided entirely from a complex source (Zinpro®; Zinpro Corporation, Eden 
Prairie, MN).  All treatments received 25 mg/d of dihydroiodide ethanediamine (EDDI) with the 
remaining supplemental iodine delivered as potassium iodide.  Supplemental selenium was 
supplied as sodium selenite across all treatments.  Supplemental iron was provided from various 
inorganic sources and did not exceed 10 mg/kg (Table 2.2).  Cows were housed at the Iowa State 
University Dairy and individually fed a TMR formulated by Dairy Health Services (Sanborn, 
IA).  All diets were isonitrogenous and isoenergentic and balanced to meet or exceed predicted 
!!
25 
25 
requirements (NRC, 2001) of energy, protein, minerals and vitamins for each stage of production 
(Tables 2.3 to 2.5).  Corn silage was the main forage source and ground corn was the primary 
concentrate (Table 2.3).  The TMR was sampled weekly, individual ingredients were sampled 
weekly, and then composited monthly and analyzed by wet chemistry methods (Table 2.5; 
Dairyland Lab Services, Arcadia, WI).   
Cows were individually fed ad libitum using the Calan Broadbent feeding system 
(American Calan, Northwood, NH).  Feed was delivered twice daily for lactating cows (0800 
and 1700 h) and once daily to the close up pen (1100 h).  Orts were determined daily one hour 
prior to feed delivery.  Immediately post-calving, cows were moved to a maternity barn where 
they were milked.  A colostrum sample was obtained, and a 300 cc oral drench of a propylene 
glycol and a calcium gel was given (Keto-gel and Cal-gel; Jorgenson Labs, Loveland, CO).  
Following initial milking, cows were moved into a “prep” pen in the lactation barn for a 
minimum of two milkings.  After passing a California Mastitis Test (CMT), cows were moved 
into the experimental pen and trained to appropriate Calan gate.  
Cows were milked twice daily at 0730 and 1800 h, and yield was recorded then 
condensed by week for statistical analysis.  Milk samples for composition analyses were 
obtained weekly from each cow beginning at seven and ending at 245 DIM ± 3 d.  The sample 
was stored at 4°C with a preservative (bronopol tablet; DandF Control System, San Ramon, CA) 
until analysis by Dairy Lab Services (Dubuque, IA) using AOAC approved infrared analysis 
equipment and procedures for milk components.  Additionally, a separate milk sample from each 
cow was collected at 105 DIM and immediately frozen at -20ºC until analysis for milk mineral 
content by the Diagnostic Center for Population and Animal Health Laboratory (Michigan State 
University, Lansing, MI).  Body weights were determined on d - 28, 0, and every 14 ± 7 d post-
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partum.  Blood samples and rectal temperatures (Tr) were obtained from all cows on d -21, -7, 3, 
7, 10, 14, 21, 28, and 56 ± 1 DIM relative to calving.  Blood samples were collected via 
coccygeal venipuncture using sodium heparin tubes (BD Vacutainer Ref 366480; Franklin 
Lakes, NJ).  Blood samples from lactating cows were obtained within one hour after feeding, and 
just prior to feeding from prefresh cows.  Samples were kept on ice until centrifuged at 2100 x g 
for 15 min, and plasma was split into two aliquots and frozen at -20°C until analysis.   
Plasma NEFA, BHBA and glucose concentrations were determined enzymatically using 
commercially available kits validated for use in our laboratory (NEFA C kit; Wako Chemicals 
USA, Richmond VA; Autokit Glucose C2; Wako Chemicals USA, Inc.).  These procedures were 
scaled down and conducted in 96-well microplates (Rainin Instrument, LLC, Oakland, CA) and 
read using a microplate photometer (SpectraMax Plus, Molecular Devices, Silicon Valley, 
California).  The inter- and intra-assay coefficients for the BHBA, NEFA and glucose assay were 
10.6, 5.8, 10.8, 6.4, 10.0 and 2.6%, respectively.  Additionally, daily observations, general 
health, and reproduction records were logged throughout the study.  
 
Colostrum Sampling and Analysis 
Colostrum samples were obtained from cows at the first milking after parturition and 
analyzed for IgG content.  To prevent calves from nursing, the calf was removed from the dam 
immediately after parturition.  Upon collection, samples were immediately frozen at -20°C and 
retained until all samples had been collected.  Colostrum IgG analysis was conducted by Global 
Beta Heath (Ames, IA).  Prior to assay, samples were diluted 1:1000 in assay buffer.  Colostrum 
IgG concentration was determined using radial immunodiffusion assay (Triple J Farms, 
Bellingham, WA). 
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Water Analysis 
 Water samples were collected from tanks in both the prefresh and lactating barn at the 
Iowa State University Dairy Farm.  Samples were acquired one week prior to trial start date 
(Prefresh and Lactating) and one month prior to trial completion (Lactating only) to test for trace 
mineral content and overall water hardness (Table 2.6).  A fresh water sample was obtained 
directly from the water tank tap after allowing water to run for four continuous minutes.  After 
sample was taken, bottle was sealed, stored at 4 ºC, and shipped within 24 h for analysis 
conducted by Dairyland Labratories, Inc. (Arcadia, WI).  
 
Calculations 
Fat corrected milk (FCM) and solids corrected milk (SCM) were calculated as described 
by Tyrrell and Reid (1965) using the following equations: 3.5% FCM = (0.432 x milk yield, kg) 
+ (16.23 x milk fat yield, kg); SCM = (0.327 x milk yield, kg) + (12.95 x milk fat yield, kg) + 
(7.2 x milk protein yield). Feed efficiency was calculated as MY/DMI, FCM/DMI, and 
SCM/DMI.  Energy balance was calculated using the following equations: EBAL = energy 
intake - energy output where energy intake = 1.41 Mcal/kg x DMI (kg) for prefresh diet, 1.68 
Mcal/kg x DMI for lactating diet and energy output = (NEM = 0.08 Mcal/kg x BW0.75) + [NEL = 
milk yield x (0.029 x fat % + 0.0547 x protein % + 0.0395 x lactose %)].  All calculations above 
were determined daily and converted to weekly averages for analysis.  Any week with less than 
four daily values was removed from the dataset. Slope of prepartum DMI change was calculated 
using weekly averages from week -3 to -1.  Slope of early lactation milk yield (MY), FCM, SCM 
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and DMI was calculated using weekly averages from week one to eight.  Slope of persistency of 
MY, FCM, SCM and DMI was calculated using weekly averages from week eight to 36. 
 
Statistical Analysis 
  Milk yield, 3.5% FCM, 4.0% SCM, milk components, DMI, FE, Tr, plasma NEFA, 
BHBA, and glucose were analyzed by repeated measures using the PROC MIXED procedure of 
SAS (2005) with an autoregressive covariance structure and week of lactation as the repeated 
effect.  The model contained week of lactation, treatment, parity (heifers vs. cows) and week of 
lactation and all possible interactions.  Cows were the random effect with week of lactation, 
treatment, and week of lactation x treatment interaction as fixed effects.  Cows were blocked by 
(1-4) season of calving and block was utilized in the model.  Single measurements (i.e. colostrum 
IgG and milk mineral content) were analyzed using the ANOVA procedure of SAS.  Least 
square means and standard errors of the mean are reported, and differences were considered 
significant when P < 0.05, unless otherwise stated.  
  
!!
29 
29 
Results 
There were no treatment differences (P > 0.10) in pre-partum DMI (11.6 kg/d; Table 2.7, 
Figure 2.2).  During lactation and compared to CON-fed cows, cows supplemented with OZn 
had an overall decrease (P < 0.01) in DMI (5.1 and 3.2% for MED and HIGH-fed cows, 
respectively; Table 2.7, Figure 2.2).  No treatment differences (P > 0.10) were observed in slope 
of DMI calculated prior to calving (-0.41 kg/wk), from week 1 to 8 (0.86 kg/wk), or from week 
eight to 36 (0.01 kg/wk; Table 2.8). 
Colostrum IgG concentration was increased (20.3%) by OZn treatment in multiparous 
cows but not in heifers (treatment by parity interaction P < 0.05), but there were no differences 
(P > 0.10) between the MED and HIGH OZn supplemented groups (Figure 2.3).  Overall milk 
yield was unaffected by OZn supplementation (37.8 kg/d; P > 0.10, Table 2.7, Figure 2.4).  
There was a decrease (P < 0.05) in overall 3.5% FCM (5.4%) and 4.0% SCM (5.1%) in the 
MED-fed group compared to CON and HIGH-fed cows (Table 2.7, Figures 2.5 and 2.6).  There 
were no treatment differences detected in the slopes of milk yield (1.89 kg/wk), FCM (0.63 
kg/wk), or SCM (0.56 kg/wk) from week one to eight (Table 2.8).  Treatment had no effect (P > 
0.10) on lactation persistency as measured as the slope of milk yield (-0.42 kg/wk) from week 
eight to 36 of lactation (Table 2.8).  Cows fed MED OZn had a steeper negative slope (P < 0.05) 
when measured as FCM (0.16 kg) and SCM (0.12 kg) compared to CON and HIGH-fed cows 
(Table 2.8).   
There was a decrease (P < 0.05) in overall milk fat content and yield in the MED-fed 
cows compared to CON and HIGH-fed cows (3.85 vs. 3.97 % and 1.42 vs. 1.51 kg/d, 
respectively, Table 2.7, Figures 2.7 and 2.8).  There was no overall treatment effect on milk 
protein content, however a treatment by week effect (P < 0.05) indicated that the CON and MED 
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groups had increased milk protein content at week 1 (Table 2.7, Figure 2.9).  Control and HIGH-
fed cows tended (P = 0.06) to have an overall increase (3.5%) milk protein yield compared to 
MED-fed cows (Table 2.7, Figure 2.10).  There was a treatment by week interaction (P < 0.01) 
for milk protein yield as MED-fed cows had decreased levels compared to CON-fed cows at 
weeks 31 and 33 and decreased levels compared to HIGH-fed cows at weeks 19, 20, 23, 26, and 
29-34 (Table 2.7, Figure 2.9).  There were no treatment (P > 0.10) differences on milk lactose 
percent or yield (Table 2.7, Figures 2.11 and 2.12).  There was an overall effect (P < 0.01) of 
supplementing OZn on MUN percent as MED-fed cows tended to have increased (P = 0.06, 
2.2%) and HIGH-fed cows had increased (P < 0.01, 5.1%) MUN compared to CON-fed cows 
(Table 2.7, Figure 2.13).  Cows fed HIGH OZn had an overall increased (P < 0.01) SCC 
compared to the CON and MED-fed groups (39 and 31%, respectively, Table 2.7, Figure 2.14).  
There was a tendency for a treatment by parity effect (P = 0.06), as OZn-fed heifers had 
increased SCC compared to CON-fed heifers and HIGH-fed cows had increased SCC compared 
to MED-fed cows (Figure 2.16).  When raw SCC was adjusted to a linear SCC (LnSCC), the 
overall treatment effect no longer existed (Table 2.7; Figure 2.15) but the treatment by parity 
interaction became significant (P < 0.01) with an increase observed in MED-fed heifers 
compared to CON-fed heifers, but both OZn treatments cows had reduced (17%) LnSCC 
compared to CON-fed cows (Table 2.7, Figure 2.16).  There was no difference in milk cobalt 
(0.50 ng/mL), copper (0.035 ug/mL), iron (0.24 ug/mL), manganese (18.67 ng/mL), 
molybdenum (42.25 ng/mL), selenium (46.40 ng/mL), and zinc (3.57 ug/mL) content between 
treatment groups at 105 DIM (Table 2.9).  
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Overall feed efficiency was increased (P < 0.05) in HIGH compared to CON-fed cows 
and this was consistent when analyzed as MY/DMI (6.2%; Table 2.10, Figures 2.17), FCM/DMI 
(5.8%; Figure 2.18), or SCM/DMI (5.9%; Figure 2.19).  There were no differences in overall 
body weight between treatments (Table 2.10, Figure 2.20), but cows supplemented with 
increasing amounts of OZn had an increased (P < 0.01) body weight (27 kg) at calving compared 
to CON-fed cows (Table 2.10).  Body weight loss (measured from calving to week 4 of lactation) 
was greater (P < 0.05; Table 2.10, Figure 2.21) in HIGH-fed cows (81 kg) compared to CON-fed 
cows (60 kg). Overall EBAL was more negative (P < 0.05) in HIGH-fed cows (-1.99 Mcal) 
compared to CON-fed cows (-0.29 Mcal), but EBAL nadir (-13.7 Mcal) did not differ amongst 
treatments (Table 2.10).  
There were no effects of OZn supplementation on overall Tr (38.4°C), peak Tr (39.0 ºC), 
DIM at peak Tr (13 d), plasma glucose (70.8 mg/dL), plasma BHBA (7.9 mg/dL), peak BHBA 
(14.2 mg/dL) concentration, or DIM at peak BHBA (18 d; Table 2.11, Figures 2.22 to 2.24).  
Cows supplemented with OZn tended (P = 0.08) to have increased plasma NEFA levels 
compared to CON-fed cows (455 vs. 409 µEq/L, Table 2.11, Figure 2.25).  There was also a 
treatment by parity interaction (P < 0.01) for plasma NEFA with an increase detected in all 
treatment by parity groups compared to CON-fed heifers (Figure 2.26).  Overall peak NEFA 
concentration (833 µEq/L) was not affected by treatment (P > 0.10) but a tendency for a 
treatment by parity interaction (P = 0.09) was apparent as CON-fed heifers had a lower peak 
NEFA (648 vs. 905 µEq/L) compared to MED-fed heifers as well as CON and HIGH-fed cows 
(Table 2.11; Figure 2.26).  There was an overall effect (P < 0.05) on DIM at peak NEFA 
concentration as CON and HIGH-fed cows reached peak NEFA levels earlier in lactation (6 vs. 
12 d) compared to MED-fed cows (Table 2.11).   
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Services per conception was improved (P < 0.01; 3.40 vs. 2.35) in HIGH and MED-fed 
cows compared to CON-fed cows (Table 2.12).  There were no differences (P > 0.10) detected in 
DIM at conception (104), days open (129), or percent of cows pregnant at any DIM evaluated 
(Table 2.12).  Statistical analysis was not conducted on health events due to limitations in sample 
size, however observations are reported (Table 2.13).   
 
Discussion 
During the periparturient period dairy cows undergo a series of well-orchestrated 
metabolic and physiological adaptations to meet the demands of lactation (Bauman and Currie, 
1980).  During the transition period, feed intake is inadequate to meet the energetic demands 
necessary for milk production and maintenance costs, and cows consequently enter into NEBAL.  
Negative energy balance is associated with (and may be the cause of) a compromised immune 
system in the transition cow (Drackely, 1999; Goff, 2006).  Trace minerals, specifically Zn, play 
key roles in immune function (Rink and Gabriel, 2001; Ibs and Rink, 2003; Rink and Hasse, 
2006), as it is a biologically essential element required for cell proliferation, tissue growth and 
maintenance, DNA synthesis and RNA transcription (Chasapis et al., 2011). 
The degree to which Zn status is believed to affect lactational performance has increased 
in accordance with the scientific understanding of its biological function.  In support of this, the 
NRC has increased the recommended dietary Zn levels for lactating dairy cows in its last 
publication (NRC, 2001).  However, bioavailability of trace minerals can be hindered by a 
variety of factors including animal’s age, gender, physiological state (i.e. growth, maintenance, 
and reproduction), environmental stress, nutritional/health status, interference by other minerals, 
form (i.e. organic vs. inorganic), interactions with naturally occurring ligands, and interactions 
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at/across intestinal lumen (Ashmead, 1991).  Trace minerals have traditionally been supplied in 
an inorganic form (i.e. sulfate or oxide), however recently organic chelation of minerals to amino 
acid complexes has been shown to increase bioavailability (Ashmead, 1991; Spears, 1996; 
Wright et al., 2008).  Further evidence demonstrates that OTM may have enhanced retention in 
the body compared to inorganic mineral sources (Ashmead, 1991; Nockels et al., 1993; Spears, 
1996).   
In addition, the NRC (2001) requirements for trace minerals may not provide an adequate 
amount for animals at higher levels of production.  For example, supplementing trace minerals 
above NRC recommendations have improved lactation performance and in some cases minerals 
supplemented at NRC levels resulted in mineral deficiencies (Kincaid et al., 2003; Weiss and 
Socha, 2005).  Despite the lack of understanding by which OZn mechanistically improves 
productivity, some explanations could be increased immune function, udder health, or improved 
GIT health.  Our hypothesis was that a mixture of inorganic and OZn at NRC (2001) 
recommended levels would increase production and or production efficiency throughout 
lactation, mediated by improved functionality or efficacy of the immune system, improved claw 
and udder health, and possibly improved GIT integrity.  An increase in overall health and 
epithelial tissue integrity could reduce the energy required to maintain these systems and 
theoretically result in more available energy thus improving production parameters.  Moreover, 
very little is known about the effects supplemental Zn has on bioenergetic parameters in blood 
(i.e. NEFA, BHBA, glucose, etc.), which is of interest in determining Zn’s role in nutrient 
metabolism of dairy cows. 
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Overall, the literature investigating organic trace mineral supplementation, specifically 
Zn, in livestock production is limited and highly variable.  One explanation is the fact that there 
are variations in the source and level of supplementation, length of treatment period, stage of 
production, species, sources of other trace minerals, and trace mineral concentration in dietary 
ingredients or water.  All of these experimental inconsistencies make it difficult to accurately 
compare our results with other trials.  Our trial is unique in that the only dietary variable that 
changed was the Zn source, as all diets were formulated to supply the same amount of 
supplementary Zn.  We also fed the experimental diets for a longer period than most other trials 
as we collected individual data from 28 days prior to expected calving date to 250 DIM.  
Furthermore, the sample size (~50 cows/treatment) in this experiment was large and this is 
particular true compared to other studies that collected individual cow data. 
In the current study, there were no treatment effects on pre-parturition DMI; both the 
MED and HIGH-fed cows had a decrease in DMI during lactation.  This contradicts two other 
studies that measured individual DMI (Cope et al., 2009; Hackbart et al., 2010), and others that 
evaluated DMI in group feeding (Ballantine et al., 2002; Nocek et al, 2006; DeFrain et al., 2009).  
It is important to note that differences in experimental design, treatments administered, length of 
treatment, treatment initiation, sample size, basal diet and breeds used between our trial and 
others make it difficult to directly compare results.  Reasons why increasing levels of OZn 
decreased DMI is not clear, but is of obvious practical and scientific interest.  
Results from this trial indicate no difference in MY when increasing supplemental 
organic Zn and this lack of an effect on raw milk yield agrees with previous reports (Toni et al., 
2007; DeFrain et al., 2009; Hackbart et al., 2010).  However, cows fed MED OZn actually had 
an overall decrease in 3.5% FCM and 4.0% SCM.  The decrease in milk fat and solids corrected 
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milk observed in the MED group is difficult to explain as feeding OTM has not reduced milk fat 
in other trials (Kincaid and Socha, 2004).   Others have reported increased milk production in 
cows fed diets with organic or sulfate sources of several trace minerals  (Ballantine et al., 2002; 
Nocek et al., 2006; Siciliano-Jones et al., 2008; Cope et al., 2009).  In a 12-trial summary 
Kellogg and colleagues (2004) reported an increase in MY, FCM, and SCM in cows 
supplemented with OZn compared to those only supplemented inorganic sources.  Some trials 
have shown no increase in milk fat, protein, and lactose yield with supplementation of OTM 
(Siciliano-Jones et al., 2008; Cope et al., 2009; DeFrain et al., 2009; Hackbart et al., 2010), 
which agrees with our results when the MED treatment group is not considered.  In contrast, 
several other studies have reported increases in milk fat and protein yield in cows fed diets with 
either organic or inorganic sources of Co, Cu, Mn, and Zn (Ballantine et al., 2002; Kellogg et al., 
2004; Nocek et al., 2006).   
An explanation for the increase in milk components yield observed in the aforementioned 
trials is improved udder health as reflected by a reduced SCC or adjusted SCC (Kellogg et al., 
2004; Nocek et al., 2006).  We observed an increase in SCC when the highest level of Zn sulfate 
was replaced with OZn, however when adjusted to linear SCC OZn-fed multiparous cows 
actually had reduced LnSCC, similar to reports by Ballantine and co-workers (2002) and 
Hackbart and colleagues (2010).  Differing from these results, others have stated reductions in 
milk SCC or adjusted SCC (Kellogg et al., 2004; Nocek et al., 2006; Siciliano-Jones et al., 2008; 
Cope et al., 2009; DeFrain et al., 2009).  Rationalization for improved mammary health is based 
on the fact that Zn is required for the maintenance of epithelial integrity, stabilization of cell 
membranes, and activation of the immune system (Miller and Madsen, 1992).  The role of Zn in 
relation to udder health is due to keratin plug formation in the teat canal, which could be why 
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OZn may reduce incidence of mastitis (Spain, 1993).  Therefore, increased Zn availability and 
retention could potentially improve immune system function and/or improve teat and mammary 
epithelial health.  As described above we did not have enough animals in this trial to accurately 
detect treatment differences on health events, but interestingly cows fed HIGH OZn had 
numerically the highest incidence of mastitis.  Clearly Zn’s role in maintaining udder health is 
not clear and warrants further investigation. 
Feed efficiency was numerically increased in the MED-fed cows and statistically 
increased by OZn supplementation at the highest inclusion level.  This is explained by the 
reduction in DMI coupled with similar milk yields observed for the HIGH-fed group.  As far as 
we are aware, there are few papers that have reported feed efficiency in dairy cows supplemented 
with increasing amounts of OZn so comparing our results with the dairy cow literature is 
difficult.  One study that reported feed efficiency indicated no difference regardless of the trace 
mineral source provided (i.e. organic or sulfates; Kincaid and Socha, 2004).  However, some 
studies conducted in other species (i.e. chickens, pigs, and beef cattle) have demonstrated an 
improvement in gain to feed ratio (Spears and Kegley, 2002; Ahola et al., 2005; Nollet et al., 
2007) although this is not always the case (Malcolm-Callis et al. 2000; Case and Carlson, 2002).   
While directly comparing results from animals at different physiological states should be 
conducted with care, it is still important to note that OZn may improve conversion of dietary 
nutrients into valued products (muscle or milk).  Two other lines of evidence support the 
increased efficiency data.  First, although EBAL nadir did not differ between treatments, overall 
EBAL (i.e. the average EBAL of weeks 1-36) was less in HIGH-fed cows.  The EBAL data was 
corroborated by the loss of body weight, which indicated that HIGH-fed cows lost 27 kg more 
than CON-fed cows within the first 4 weeks of lactation.  Overall body weight (average between 
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weeks 1 and 36 of lactation) did not differ amongst treatments and this indicates that HIGH-fed 
cows were able to replenish body reserves during later stages of lactation.  Our results for body 
weight parameters are similar to observations by Hackbart and colleagues (2010), who indicated 
no overall effect of treatment but increased body weight loss in the first month of lactation in 
cows supplemented with OZn.   
Assessing Zn status, though challenging, becomes important as Zn deficiencies can result 
in decreased growth, milk production, feed efficiency, immune function, and reproduction.  
Without knowledge or ability to accurately measure Zn status it is difficult to attribute positive 
production responses to increased Zn supplementation above minimum requirements or simply a 
return to required Zn supplementation rate.  For this reason we measured milk mineral content at 
105 DIM to determine if this could be a valid way to measure Zn status of a lactating dairy cow.  
However, we did not detect differences in any mineral measured, but this is similar to results 
reported by Cope and colleagues (2009).  Treatment effects may not have been measurable due 
to the lack of repeated measures but there is no evidence at this time that milk mineral content 
can be used to evaluate mineral status or retention.  This agrees with other trials that have 
measured plasma or tissue mineral concentrations and have reported no differences in animals 
supplemented with increasing OTM (Siciliano-Jones et al., 2008; Cope et al., 2009). 
Plasma NEFA, BHBA, glucose and rectal temperature were measured to determine if 
OZn had effects on tissue catabolism and/or metabolism.  In the present study, although the 
temporal pattern for BHBA, glucose and Tr followed the expected trend, no overall treatment 
differences were detected for these variables.  However, there was a tendency for an increase in 
plasma NEFA in cows supplemented with OZn.  The elevated plasma NEFA also corroborates 
the increased feed efficiency and correlates well with the increased body weight loss in the MED 
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and HIGH-fed cows.  Another trial previously measured plasma NEFA levels in cows fed trace 
mineral complexes compared to trace minerals provided as sulfates and reported no difference 
(Kincaid and Socha, 2004). We suspect that the effect of increasing OZn on NEFA levels is an 
indirect consequence of reduced DMI and not a direct post-absorptive effect of Zn on adipose 
tissue mobilization. 
 The importance of Zn in cell proliferation becomes especially apparent when it comes to 
high proliferating tissues (i.e. skin/hair, GIT epithelia, reproductive tract).  Deficiencies in Zn 
can lead to reduced ovulation, poor oocyte quality, abortion, fetal malformations, lower birth 
weights and offspring with reduced or defective immune function (Hurley and Shrader, 1975; 
Record et al., 1985; Apgar, 1992).  This is of great concern and interest to the dairy industry 
because of lower reproduction rates compared to other livestock species and the economic 
consequence of poor fecundity.  In theory, supplying a more bioavailable form of Zn should 
provide benefits to reproductive indices in high producing dairy cows.   
Results from our trial suggest that supplementing OZn improved a key aspect of 
reproduction as OZn-fed cows showed reduced services per conception compared to CON-fed 
cows.  There were no other treatment differences detected in other reproductive indices, but it 
did appear that OZn supplementation may reduce (at least numerically) DIM at conception, days 
open, and increased percent of cows pregnant especially in early lactation.  Ballantine and co-
workers (2002), reported a decrease in days open and a tendency for an increase in cows 
pregnant at 150 DIM and first service conception rate in cows supplemented with a mixture of 
OTM.  Similarly, Nocek and colleagues (2006) demonstrated improvements in reproductive 
indices as cows fed a mixture of OTM and sulfates tended to have fewer services per conception, 
less days open, and lower calving interval and had a decrease in days to first estrus compared to 
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cows receiving only OTM or trace minerals from sulfates at the same level in the first lactation.  
The trial mentioned previously continued for a second lactation with the same cows, and 
reproductive parameters again were improved as cows fed a mixture of OTM and sulfates had 
higher first service conception rates, cycled sooner after calving, and had more cows pregnant by 
150 DIM (Nocek et al., 2006).  Another trial also reported a tendency for percent of cows 
pregnant at 150 DIM in cows fed OTM (including Zn; DeFrain et al., 2009).  While some trials 
have reported improved reproductive indices (Uchida et al., 2001; Ballantine et al., 2002; Nocek 
et al., 2006; DeFrain et al., 2009), similar to our results, others have concluded no effect of trace 
mineral source on reproduction (Siciliano-Jones et al., 2008; Hackbart et al., 2010).  While 
results have been somewhat variable it is apparent that research has demonstrated a positive 
effect of supplementing OTM on reproductive performance in dairy cows.   
 
Conclusions 
 Results from this study suggest that supplementing increasing levels of OZn prior to and 
for the remainder of lactation improves overall FE via decreasing overall DMI while maintaining 
milk production (with the exception of the MED-fed group).  Specific reasons for the decreased 
performance in MED-fed cows (after week 16) are unclear.  However, we do not feel 
performance was negatively influenced by treatment but are more likely explained by a natural 
cow-by-cow variation or removal of cows for various health reasons.  The fact that cows 
supplemented with OZn lost more BW in early lactation, had higher overall NEFA levels, and a 
lower overall EBAL corresponds to the decreased DMI observed, as cows consuming less would 
have a lower energy intake coupled with a similar energy output.  Therefore, these cows would 
have to mobilize more body tissue reserves in order to support production.  While cows 
!!
40 
40 
supplemented with OZn lost more BW in early lactation overall BW was not different which 
means OZn-fed cows were able to replenish body reserves.  Interestingly, number of services per 
conception was improved with supplementing increasing levels of OZn in spite of the decreased 
energy intake and similar energy output.  Overall, our results indicate that supplementing Zn as 
mixture of OZn and Zn sulfate, as opposed to supplementing only Zn sulfate, has beneficial 
effects on production parameters in dairy cows with those benefits becoming more apparent as 
OZn level increased.   
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Table 2.1: Treatment allocation and previous 305 ME. 
 Treatment  
 CON MED HIGH Total 
Heifers 26 21 21 68 
Cows 28 24 27 79 
Total 54 45 48 147 
Previous 305 ME 28846 29109 29488  
Week of Lactation 
Figure 2.1: Experimental schematic by week of lactation throughout trial. 
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Table 2.2: Trace mineral levels in vitamin pack. 
 Control  Medium Zinc  High Zinc 
 Inorganic Complexes  Inorganic Complexes  Inorganic Complexes 
Close-up1         
    Zn 75.0 0  41.7 33.3  8.4 66.6 
    Mn 41.5 18.5  41.5 18.5  41.5 18.5 
    Cu 3.4 11.6  3.4 11.6  3.4 11.6 
    Co 0 1.11  0 1.11  0 1.11 
    Fe <10 0  <10 0  <10 0 
    I 0.9 0  0.9 0  0.9 0 
    Se 0.3 0  0.3 0  0.3 0 
Lactation2         
    Zn 75.0 0  59.5 15.5  35.0 40.0 
    Mn 51.4 8.6  51.4 8.6  51.4 8.6 
    Cu 9.6 5.4  9.6 5.4  9.6 5.4 
    Co 0 1.08  0 1.08  0 1.08 
    Fe <10 0  <10 0  <10 0 
    I 0.9 0  0.9 0  0.9 0 
   Se 0.3 0  0.3 0  0.3 0 
1Estimated using a dry matter intake of 10.6 kg/d during the 21-d close-up phase. 
2Estimated using a dry matter intake of 23.2 kg/d from 1-250 DIM phase. 
   
!!
43 
43 
 
 
 
  
Table 2.3: Ingredient formulation of the diet. 
Item      Prefresh    Lactation 
Ingredient, % DM   
Alfalfa hay 18.3 10.2 
Oat straw 27.1 - 
Corn silage 38.5 47.1 
Corn grain, ground 4.6 8.6 
Whole cottonseed - 9.0 
Soybean hulls - 8.9 
Soybean meal, 48% - 6.1 
Soybean meal, 44% 7.0 - 
Amino-Plus2 - 5.1 
Fish meal, menhaden - 1.12 
Limestone 0.51 0.78 
Animal fat - 0.64 
Magnesium sulfate 0.80 0.58 
Urea - 0.58 
Sodium bicarbonate - 0.53 
Ammonium chloride 0.51 - 
Salt 0.25 0.43 
Blood meal 1.22 - 
Dicalcium phosphate - 0.20 
Selenium 200 0.08 - 
Diamond V XP yeast3 0.51 - 
Vitamin E 0.42 - 
Vitamin/mineral pack 0.17 0.14 
Rumensin 804 0.011 0.005 
1 The prepartum diet was fed for approximately 28 d.  The lactation ration was fed from 1 to 250 
DIM. 
2 Amino-Plus heat-treated soybean meal (Ag Processing, Inc., Omaha, NE). 
3 Diamond V XP yeast fermentation metabolites of Saccharomyces cerevisiae (Diamond V Mills, 
Cedar Rapids, IA). 
4 Rumensin 80, monensin mono-sodium salt (Elanco Animal Health, Greenfield, IN). 
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Table 2.4: Dietary composition of the formulated prefresh and lactation rations. 
Item       Prefresh     Lactation 
Composition, % DM   
CP, % 13.9 17.6 
NEL, mcal/kg 1.41 1.68 
ADF, % 29.2 23.9 
NDF, % 42.8 35.3 
NFC, % 33.1 35.4 
Starch, % 19.4 23.8 
Fat, % 2.6 5.1 
Ash, % 8.4 7.4 
Ca, % 0.75 0.78 
P, % 0.22 0.39 
Mg, % 0.39 0.37 
K, % 1.59 1.22 
Na, % 0.26 0.35 
Cl, % 0.87 0.46 
S, % 0.30 0.26 
Vitamin A, KIU/kg 11.10 9.12 
Vitamin D, KIU/kg 3.35 2.76 
Vitamin E, IU, kg 212.34 25.40 
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Table 2.5: Dietary composition of the actual prefresh and lactation rations. 
 Prefresh1  Lactation2 
Item CON MED HIGH  CON MED HIGH 
Composition, % DM   
CP, % 11.5 11.5 11.5  14.9 14.9 15.0 
NEL, Mcal/kg     1.34 1.34 1.34  1.61 1.61 1.61 
ADF, % 33.1 33.1 33.1  16.3 16.3 16.3 
NDF, % 50.8 50.8 50.8  37.2 37.4 37.3 
NFC, % 28.5 28.5 28.5  38.3 38.2 38.2 
Starch, % 16.1 16.1 16.1  21.5 21.5 21.5 
 Fat, %     2.2 2.2 2.2  4.3 4.3 4.3 
Ash, %   7.4 7.4 7.4  5.9 5.9 5.9 
Ca, %     0.60 0.61 0.60  0.63 0.64 0.65 
P, %     0.27 0.27 0.27  0.36 0.36 0.36 
Mg, %     0.18 0.18 0.18  0.23 0.23 0.23 
K, %     1.46 1.45 1.46  1.15 1.15 1.15 
Na, %     0.10 0.10 0.10  0.20 0.20 0.21 
Cl, %     0.44 0.44 0.44  0.28 0.28 0.29 
S, %     0.17 0.17 0.16  0.21 0.21 0.21 
Zn, ppm 59.7 59.2 54.5  92.3 85.6 92.9 
Mn, ppm 45.8 41.6 46.3  62.5 66.5 66.9 
Cu, ppm 12.4 13.1 11.7  19.4 22.7 19.3 
Fe, ppm   233 233 231  259 271 259 
Mb, ppm      1.17 1.16 1.17  0.98 0.97 0.99 
1Treatments were Zn Sulfate (CON); 33.3 mg/kg OZn from Availa®Zn (MED); 66.6 mg/kg OZn from 
Availa®Zn (HIGH)  
2Treatments were Zn Sulfate (CON); 15.5 mg/kg OZn from Availa®Zn (MED); 40.0 mg/kg OZn from 
Availa®Zn (HIGH)  
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Table 2.6: Iowa State Dairy farm water analysis1. 
 Pre-fresh Barn (ppm) 
Lactating Barn Initial 
(ppm) 
 
Lactating Barn Final 
(ppm) 
 Nitrite 5.21 5.08 1.07 
pH 7.71 8.70 8.48 
Calcium 38.04 34.90 37.71 
Magnesium 18.54 18.19 24.23 
Phosphorous 1.64 0.25 0.08 
Potassium 2.97 2.39 3.15 
Copper 0.02 <0.01 0.01 
Iron 0.06 0.03 0.04 
Zinc 0.14 0.02 0.04 
Sodium 12.19 11.73 30.55 
Manganese  0.01 <0.01 0.01 
Chloride 33.00 27.00 47.00 
Sulfates 57.42 56.79 110.46 
Total Dissolved 
sSolids 
260.00 255.00 335.00 
Water Hardness 171 162 194 
1Livestock water analysis conducted by Dairyland Laboratories, Inc. (Arcadia, WI). 
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Table 2.7: Effect of supplementing increasing amounts of organic zinc on production parameters1. 
 Treatment2  P 
Parameter CON MED HIGH SEM    TRT TRT x WOL TRT x  WOL x Parity 
DMI Pre3, kg 12.0 11.3 11.6 0.3 0.12 0.22 0.71 
DMI Post4, kg 21.7a 20.6b 21.0b 0.3 < 0.01 0.27 0.87 
Milk Yield, kg/d 37.9 36.9 38.5 0.6 0.17 0.36 0.92 
3.5% FCM5, kg/d    40.7a    38.7b    41.1a 0.7 < 0.05 0.19 0.75 
4.0% SCM6, kg/d    36.8a    35.1b    37.1a 0.6 < 0.05 0.22 0.82 
Colostrum IgG, mg/mL   87.5      92.2      98.1             5.3 0.33 - - 
Milk Composition        
Fat, %       3.99a      3.85b       3.94ab      0.04 < 0.05 0.34 0.31 
Fat Yield, kg/d       1.51a      1.42b      1.51a      0.02 < 0.01 0.16 0.20 
Protein, %      2.97     2.97     2.97      0.02 1.00 < 0.05 0.99 
Protein Yield, kg/d      1.12     1.09     1.14      0.01 0.06 < 0.01 0.95 
Lactose, %      4.86     4.83     4.83      0.01 0.21 0.98 0.65 
Lactose Yield, kg/d      1.84     1.79     1.86      0.03 0.14 0.86 0.97 
Other Solids, %      5.76     5.74 5.73       0.01 0.23 0.99 0.62 
Total Solids, %     12.71   12.55   12.64       0.05 0.07 0.15 0.24 
MUN7, % 14.9a   15.3b   15.7c 0.1 < 0.01 0.77 0.65 
SCC, 1000/mL 188.9a  212.3a 307.3b 29.2 < 0.01 0.95 0.44 
LnSCC8      2.33     2.31     2.24       0.11 0.81 0.81 0.19 
1Average over the 36 week post-partum period, unless otherwise noted  
2Treatments were Zn Sulfate (CON); 15.5 mg/kg OZn from Availa®Zn (MED); 40.0 mg/kg OZn from Availa®Zn (HIGH)  
3Dry matter intake for 3 weeks prepartum  
4Dry matter intake for 36 weeks postpartum 
5Fat Corrected Milk = (0.432 x milk yield) + (16.23 x milk fat yield) 
6Solids Corrected Milk = (12.24 x milk fat yield) + (7.1 x milk protein yield) + (6.35 x milk lactose yield) – (0.0345 x milk yield) 
7Milk Urea Nitrogen 
8Somatic Cell Count Linear Score 
a,b,c Values within rows with differing superscripts indicate P ≤ 0.05 
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Table 2.8: Effect of supplementing increasing amounts of organic zinc on slope of milk 
yield and dry matter intake to peak and from peak to the end of the trial.1 
 Treatment2  P 
Parameter CON MED HIGH SEM TRT TRT x Parity 
Wk -13       
DMI -0.44 -0.58 -0.21 0.20 0.41 0.50 
Wk 84       
DMI 0.81 0.99 0.78 0.09 0.17 0.82 
MY  1.87 1.91 1.88 0.12 0.97 0.67 
FCM 0.48 0.69 0.73 0.20 0.59 <0.01 
SCM 0.43 0.57 0.68 0.17 0.53 <0.05 
Wk 365       
DMI 0.02 -0.02 0.03 0.02 0.28 0.39 
MY -0.41 -0.47 -0.39 0.03 0.16 0.83 
FCM -0.33a -0.48b -0.34a 0.04 <0.01 0.34 
SCM -0.28a -0.40b -0.28a 0.03 <0.05 0.31 
1Slope = change in weekly averages over time  
2Treatments were Zn sulfate (CON); 15.5 mg/kg OZn from Availa®Zn (MED); 40.0 mg/kg OZn 
from Availa®Zn (HIGH) 
3Slope from week -3 to -1 
4Slope from week 1 to 8 
5Slope from week 8 to 36 
a,b Values within rows with differing superscripts indicate P < 0.05 
Table 2.9: Effect of supplementing increasing amounts of organic zinc on milk mineral 
content at 105 DIM. 
 Treatment1  P 
Mineral CON MED HIGH SEM     TRT TRT x Parity 
Cobalt, ng/mL 0.40 0.48      0.61 0.08 0.12 0.20 
Copper, ug/mL    0.034 0.033 0.037 <0.01 0.49 0.77 
Iron, ug/mL 0.21 0.22      0.30 0.04 0.23 0.25 
Manganese, ng/mL 17.98  18.63    19.40 0.74 0.33 0.51 
Molybdenum, ng/mL 41.24   41.92    43.59 1.38 0.40 0.26 
Selenium, ng/mL 45.77   45.88    47.54 0.77 0.15 0.73 
Zinc, ug/mL 3.61     3.62      3.48 0.12 0.62 0.80 
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Table 2.10: Effect of supplementing increasing amounts of organic zinc on feed efficiency, body weight, and energy balance1. 
 Treatment2  P 
Parameter CON MED HIGH SEM    TRT TRT x WOL TRT x  WOL x Parity 
Feed Efficiency        
MY/DMI, kg  1.83a 1.89ab 1.95b         0.04 <0.05 0.46 0.71 
FCM/DMI, kg 1.96a 2.00ab 2.08b         0.04 <0.05 0.44 <0.05 
SCM/DMI, kg 1.76a 1.80ab 1.87b         0.03 <0.05 0.37 0.08 
BW3, kg   614 616  619 5 0.77 <0.01 <0.01 
BW 04, kg    642a 661b  677b 6 <0.01 - - 
BW ∆5, kg    -60a -72ab   -81b 6 <0.05 - - 
EBAL6, Mcal -0.29a -0.96ab -1.99b          0.44 <0.05 0.29 0.54 
EBAL Nadir, Mcal    -12.5  -14.1   -14.4        0.8 0.22 - - 
1Average over the 36 week post-partum period unless otherwise noted 
2Treatments were Zn Sulfate (CON); 15.5 mg/kg OZn from Availa®Zn (MED); 40.0 mg/kg OZn from Availa®Zn (HIGH)  
3Overall body weight  
4Body weight at calving  
5Body weight change from calving to week 4 
6Energy balance = NEintake - NEoutput 
a,b Values within rows with differing superscripts indicate P < 0.05 
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Table 2.11: Effect of supplementing increasing amounts of organic zinc on rectal temperature and plasma metabolites. 
 Treatment1  P 
Parameter CON MED HIGH SEM TRT DIM TRT x DIM 
TRT x DIM x 
Parity 
Tr2, °C    38.4    38.4    38.4      0.03 0.31 <0.01 0.24 0.28 
Pk Tr3, ºC    38.9    38.9    39.1         0.1 0.16 - - - 
DIM Pk Tr4, d       12        15       11         3 0.59 - - - 
Glucose, mg/dL    70.4    71.8    70.2         0.8 0.27 <0.01 0.65 0.55 
NEFA5, µEq/L     409      455     454       18 0.08 <0.01 0.67 0.84 
Pk NEFA6, µEq/L     765      892     842       57 0.24 - - - 
DIM Pk NEFA7, d         7a        12b         4a         2 <0.05 - - - 
BHBA8, mg/dL       7.7      7.8      8.2         0.3 0.57 <0.01 0.10 0.72 
Pk BHBA9, mg/dL     13.9    13.9    14.8         4.2 0.86 - - - 
DIM Pk BHBA10, d       21        17       15         3 0.15 - - - 
1Treatments were Zn Sulfate (CON); 15.5 mg/kg OZn from Availa®Zn (MED); 40.0 mg/kg OZn from Availa®Zn (HIGH)  
2Rectal temperature 
3Peak rectal temperature 
4Days in milk at peak rectal temperature 
5Nonesterified fatty acid 
6Peak NEFA 
7Days in milk at peak NEFA  
8β-hydroxybutyrtic acid 
9Peak BHBA 
10Days in milk at peak BHBA   
a,b Values within rows with differing superscripts indicate P < 0.05 
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Table 2.12: Effect of supplementing increasing amounts of organic zinc on reproduction parameters. 
 Treatment1  P 
Parameter CON MED HIGH SEM TRT TRT x Parity 
DIM at Conception, d   114     92    107         8 0.13 0.77 
Services/ Conception  3.4a   2.1b    2.6b  0.3 <0.01 0.95 
Days Open   139   122    127       11 0.49 0.98 
Percent Pregnant2       
75 DIM, % 21.1 36.8 28.3 7.1 0.27 0.55 
100 DIM, % 35.4 49.1 43.2 7.8 0.41 0.92 
125 DIM, % 48.3 63.1 54.0 7.6 0.36 0.63 
150 DIM, % 59.3 66.5 59.4 7.4 0.72 0.42 
175 DIM, % 66.3 74.2 65.5 7.1 0.62 0.68 
200 DIM, % 74.7 75.4 74.5 6.8 0.99 0.94 
250 DIM, % 80.8 82.0 83.1 6.2 0.96 0.79 
1Treatments were Zn Sulfate (CON); 15.5 mg/kg OZn from Availa®Zn (MED); 40.0 mg/kg OZn from Availa®Zn (HIGH)  
2Values represent number of cows pregnant/ number of cows on trial for each treatment at specified time point 
 
Table 2.13: Effect of supplementing increasing amounts of organic zinc on health events. 
 Treatment1  
Parameter CON MED HIGH Total, % (#) 
Digestive2, % (#) 3.7 (2) 2.2 (1) 8.5 (4) 4.8 (7) 
Displaced abomasum, % (#) 1.9 (1) 6.5 (3) 8.5 (4) 5.4 (8) 
Ketosis, % (#) 5.6 (3) 8.7 (4)   19.1 (9)     10.9 (16) 
Mastitis, % (#)     20.4 (11)     41.3 (19)     57.4 (27)     38.8 (57) 
Metritis, % (#) 3.7 (2) 6.5 (3)   10.6 (5)       6.8 (10) 
Miscellaneous3, % (#)     7.4 (4)   10.9 (5)    10.6 (5)       9.5 (14) 
Respiratory4, % (#)     3.7 (2)     4.3 (2)      4.3 (2)      4.1 (6) 
1Treatments were Zn Sulfate (CON); 15.5 mg/kg OZn from Availa®Zn (MED); 40.0 mg/kg OZn from Availa®Zn (HIGH)  
2Represents acidosis or other digestive disorders 
3Represents milk fever, retain placenta, or other health events not listed above 
4Represents cows treated for pneumonia or any other respiratory health event  
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Figure 2.2: Effects of increasing levels of dietary organic zinc on overall (A) dry matter intake (DMI) and the interaction between treatment 
and parity on DMI (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 mg/kg of DM 
with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment initiation 
occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. SEM averaged!0.51 (A) and 0.72 kg (B).!
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Figure 2.3: Effects of increasing levels of dietary organic zinc on overall colostrum  
IgG (A) and the interaction between treatment and parity on IgG concentration (B).  
Control (CON) cows received no OZn supplementation, Medium (MED) cows were 
supplemented 15.5 mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) 
cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment 
initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent 
LS means for the CON, MED, and HIGH Availa®Zn supplementation. Values within 
plot with differing letters indicate P < 0.05. 
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Figure 2.4: Effects of increasing levels of dietary organic zinc on overall (A) milk yield and the interaction between treatment and parity on 
milk yield (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 mg/kg of DM with 
Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment initiation 
occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. SEM averaged 0.85 (A) and 1.19 (B).!!
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Figure 2.5: Effects of increasing levels of dietary organic zinc on overall (A) 3.5% FCM and the interaction between treatment and parity on 
3.5% FCM (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 mg/kg of DM with 
Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment initiation 
occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. SEM averaged 1.07 (A) and 1.50 (B). 
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Figure 2.6: Effects of increasing levels of dietary organic zinc on overall (A) 4.0% SCM and the interaction between treatment and parity on 
4.0% SCM (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 mg/kg of DM with 
Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment initiation 
occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. SEM averaged 0.91 (A) and 1.27 (B). 
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Figure 2.7: Effects of increasing levels of dietary organic zinc on overall (A) milk fat content and the interaction between treatment and parity 
on milk fat content (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 mg/kg of DM 
with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment initiation 
occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. SEM averaged 0.11 (A) and 0.16 % units (B).  !
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Figure 2.8: Effects of increasing levels of dietary organic zinc on overall (A) milk fat yield and the interaction between treatment and parity on 
milk fat yield (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 mg/kg of DM with 
Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment initiation 
occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. SEM averaged 0.05 (A) and 0.07 kg (B). !
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Figure 2.9: Effects of increasing levels of dietary organic zinc on overall (A) milk protein content and the interaction between treatment and 
parity on milk protein content (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 
mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. 
Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH 
Availa®Zn supplementation. SEM averaged 0.04 (A) and 0.05 % units (B).  Differences with a P < 0.05 are denoted by *.!
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Figure 2.10: Effects of increasing levels of dietary organic zinc on overall (A) milk protein yield and the interaction between treatment and 
parity on milk protein yield (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 mg/kg 
of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment 
initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. SEM averaged 0.02 (A) and 0.04 kg (B). Differences with a P < 0.05 are denoted by *.!
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Figure 2.11: Effects of increasing levels of dietary organic zinc on overall (A) milk lactose content and the interaction between treatment and 
parity on milk lactose content (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 
mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. 
Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH 
Availa®Zn supplementation. SEM averaged 0.03 (A) and 0.04 % units (B). !
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Figure 2.12 Effects of increasing levels of dietary organic zinc on overall (A) milk lactose yield and the interaction between treatment and 
parity on milk lactose yield (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 mg/kg 
of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment 
initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. SEM averaged 0.04 (A) and 0.06 kg (B). !
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Figure 2.13: Effects of increasing levels of dietary organic zinc on overall (A) MUN content and the interaction between treatment and parity 
on MUN content (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 mg/kg of DM 
with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment initiation 
occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. SEM averaged 0.41 (A) and 0.58 % units (B). !
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Figure 2.14: Effects of increasing levels of dietary organic zinc on overall (A) somatic cell count (SCC, 1000/mL) and the interaction between 
treatment and parity on SCC (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 mg/kg 
of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment 
initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. SEM averaged 125 (A) and 176 (B). !
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Figure 2.15: Effects of increasing levels of dietary organic zinc on overall (A) linear somatic cell count (LnSCC) and the interaction between 
treatment and parity on LnSCC (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 
mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. 
Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH 
Availa®Zn supplementation. SEM averaged 0.24 (A) and 0.34 (B). !
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Figure 2.16: Effects of increasing levels of dietary organic zinc on overall interaction 
between treatment and parity on somatic cell count (SCC, 1000/mL; A) and linear 
SCC (LnSCC; B). Control (CON) cows received no OZn supplementation, Medium 
(MED) cows were supplemented 15.5 mg/kg of DM with Availa®Zn post-partum and 
HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-
partum. Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 
DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. Values within plot with differing letters indicate P < 0.05. 
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Figure 2.17: Effects of increasing levels of dietary organic zinc on overall (A) feed efficiency (milk yield/dry matter intake) and the interaction 
between treatment and parity on feed efficiency (MY/DMI; B). Control (CON) cows received no OZn supplementation, Medium (MED) cows 
were supplemented 15.5 mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with 
Availa®Zn post-partum. Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the 
CON, MED, and HIGH Availa®Zn supplementation. SEM averaged 0.07 (A) and 0.10 kg (B). !
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Figure 2.18: Effects of increasing levels of dietary organic zinc on overall (A) feed efficiency (fat-corrected milk/dry matter intake) and the 
interaction between treatment and parity on feed efficiency (FCM/DMI; B). Control (CON) cows received no OZn supplementation, Medium 
(MED) cows were supplemented 15.5 mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of 
DM with Availa®Zn post-partum. Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means 
for the CON, MED, and HIGH Availa®Zn supplementation. SEM averaged 0.07 (A) and 0.10 kg (B). !
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Figure 2.19: Effects of increasing levels of dietary organic zinc on overall (A) feed efficiency (solids-corrected milk/dry matter intake) and the 
interaction between treatment and parity on feed efficiency (SCM/DMI; B). Control (CON) cows received no OZn supplementation, Medium 
(MED) cows were supplemented 15.5 mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of 
DM with Availa®Zn post-partum. Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means 
for the CON, MED, and HIGH Availa®Zn supplementation. SEM averaged 0.06 (A) and 0.09 kg (B). !
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Figure 2.20: Effects of increasing levels of dietary organic zinc on overall (A) body weight (kg) and the interaction between treatment and 
parity on body weight (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 mg/kg of 
DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment 
initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH Availa®Zn 
supplementation. SEM averaged 6.9 (A) and 9.6 kg (B). !
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Figure 2.21: Effects of increasing levels of dietary organic zinc on overall (A) energy balance (EBAL, Mcal) and the interaction between 
treatment and parity on EBAL (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were supplemented 15.5 
mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. 
Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS means for the CON, MED, and HIGH 
Availa®Zn supplementation. SEM averaged 0.90 (A) and 1.26 Mcal (B). !
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Figure 2.22: Effects of increasing levels of dietary organic zinc on overall (A) rectal temperature (Tr, °C) and the interaction 
between treatment and parity on Tr (B). Control (CON) fed cows received no OZn supplementation, Medium (MED) cows were 
supplemented 15.5 mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with 
Availa®Zn post-partum. Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS 
means for the CON, MED, and HIGH Availa®Zn supplementation. SEM averaged 0.07 (A) and 0.10 ºC (B). !
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Figure 2.23: Effects of increasing levels of dietary organic zinc on overall (A) plasma glucose (mg/dL) and the interaction between 
treatment and parity on plasma glucose (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were 
supplemented 15.5 mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with 
Availa®Zn post-partum. Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS 
means for the CON, MED, and HIGH Availa®Zn supplementation. SEM averaged 1.9 (A) and 2.7 mg/dL (B). !
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Figure 2.24: Effects of increasing levels of dietary organic zinc on overall (A) BHBA (mg/dL) and the interaction between 
treatment and parity on BHBA (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were 
supplemented 15.5 mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with 
Availa®Zn post-partum. Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS 
means for the CON, MED, and HIGH Availa®Zn supplementation. SEM averaged 0.72 (A) and 1.02 mg/dL (B). !
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Figure 2.25: Effects of increasing levels of dietary organic zinc on overall (A) NEFA (µEq/L) and the interaction between 
treatment and parity on NEFA (B). Control (CON) cows received no OZn supplementation, Medium (MED) cows were 
supplemented 15.5 mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) cows were supplemented 40 mg/kg/ of DM with 
Availa®Zn post-partum. Treatment initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent LS 
means for the CON, MED, and HIGH Availa®Zn supplementation. SEM averaged 40 (A) and 55 µEq/L (B). !
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Figure 2.26: Effects of increasing levels of dietary organic zinc on overall interaction 
between treatment and parity on NEFA (µEq/L; A) and peak NEFA (B). Control 
(CON) cows received no OZn supplementation, Medium (MED) cows were 
supplemented 15.5 mg/kg of DM with Availa®Zn post-partum and HIGH (HIGH) 
cows were supplemented 40 mg/kg/ of DM with Availa®Zn post-partum. Treatment 
initiation occurred 28 ± 15 d prior to calving and ceased at 250 DIM. Values represent 
LS means for the CON, MED, and HIGH Availa®Zn supplementation.  Values within 
plot with differing letters indicate P < 0.05. 
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APPENDIX 1 
CHARACTERIZING THE TEMPORAL AND SEASONAL PATTERN OF 
PLASMA LIPOPOLYSACCHARIDE BINDING PROTEIN DURING THE 
TRANSITION PERIOD 
 
Abstract 
During the periparturient period and heat stress (HS), dairy cows are more 
susceptible to rumen acidosis, which may compromise the gastrointestinal tract’s (GIT) 
barrier function.  Infiltrating lipopolysaccharide (LPS) is bound by LPS binding protein 
(LBP), but the role of LBP in dairy cow physiology is not well known.  To investigate 
this, production data and blood samples were collected on lactating Holstein cows (n = 
44; 5 cows were used in both the winter and “good” analyses) housed in a free stall barn 
and fed individually from -21 to 21 DIM.  Two analyses were conducted: 1) “good” vs. 
“poor” transition cows and 2) winter vs. summer (July 2011) calving cows.  It is 
important to note that five of the 40 cows were used as part of the winter and “good” 
analyses.  Poor transition cows (n = 7) were defined as those treated for ketosis within 22 
days after parturition.  Conversely, good transition cows (n = 9) were void of a diagnosed 
health problem during the transition period.  Cows included in the winter (n = 24) vs. 
summer (n = 5) analysis did not experience a diagnosed health event.  Irrespective of 
classification, plasma LBP levels were lowest prior to calving and peaked at 3 DIM then 
slowly returned to pre-parturition concentrations by 21 DIM.  Overall, “poor” 
transitioning cows had increased (21%, P = 0.04) circulating LBP compared to “good” 
transition cows and the difference was most pronounced (> 2 fold) on 3 DIM. Non-
esterified fatty acid and BHBA levels were not different between “good” and “poor” 
transitioning cows.  However, we observed strong correlations between peak LBP and the 
transition success measures, milk yield slope (r = -0.58, P < 0.05) and BHBA area under 
78 
!
78 
the curve (r = 0.72, P < 0.01).  Interestingly, winter calving cows had 52% (P = 0.05) 
greater LBP than summer calving cows and the difference was most pronounced (82%) at 
3 DIM.  In these cows, peak LBP was also negatively associated with average milk yield 
(r = -0.49, P < 0.01) and day 1-21 dry matter intake slope (r = -.57, P < 0.05).  Taken 
together, we hypothesize that circulating LBP concentration may play a role in 
determining seasonal and transition period success, or at least is closely associated with 
periparturient performance. 
 
Materials And Methods 
A subset of cows (n = 44) was selected for lipopolysaccharide binding protein 
(LBP) analysis.  Two analyses were conducted: 1) “good” vs. “poor” transition cows and 
2) winter vs. summer (July 2011) calving cows.  Poor transition cows (n = 7) were 
defined as those treated for ketosis within 22 days after parturition.  Conversely, good 
transition cows (n = 9) were devoid of a diagnosed health problem during the transition 
period.  Cows included in the winter (n = 24) vs. summer (n = 5) analysis did not 
experience a diagnosed health event.  The analysis included blood samples taken on  -21, 
-7, 3, 7, 10, and 21 ± 1 d relative to calving.  Blood samples were collected via coccygeal 
venipuncture using sodium heparin vacutainers (BD Vacutainer Ref 366480; Franklin 
Lakes, NJ).  Blood samples from lactating cows were obtained within one hour after 
feeding, and blood samples from prefresh cows were collected just prior to feeding, kept 
on ice until centrifuged at 2100 x g for 15 min, then plasma was split into two aliquots 
and frozen at -20°C until analysis.   
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Plasma concentration of LBP was determined enzymatically using a 
commercially available kit (LBP for a wide variety of species HK503; Hycult biotech, 
Plymouth Meeting, PA).  Prior to analysis for LBP, samples were diluted 1:800 in assay 
buffer.  Plasma NEFA, BHBA, and glucose were determined using commercially 
available kits (NEFA C kit; Wako Chemicals USA, Richmond VA; Autokit Glucose C2; 
Wako Chemicals USA, Inc.).  Body weights were determined on days -28, 0, 14, and 28; 
an average daily weight was calculated using postpartum weights, which were then used 
to calculate net energy of maintenance.   
Daily feed intake and milk yield was obtained on all cows.  Milk samples were 
taken for composition analysis on 7, 14, and 21 DIM; results were assigned to three days 
before and after the actual sample day (except 7 DIM which was assigned to 1-10 DIM) 
to obtain daily energy output in milk.  Feed samples were taken weekly to determine dry 
matter (DM) content; results were applied to three days before and after the actual sample 
day, and daily DM intake (DMI) was calculated.  Energy intake was calculated using net 
energy of lactation values obtained from the diet formulation.   
Additionally, daily observations, general health, and reproduction records were 
logged throughout the study.  All daily values, excluding plasma metabolites, were 
converted into weekly means prior to analysis and any week having less than four daily 
values was removed from data set.  After determining the differences in LBP 
concentration between health status and season all data was pooled to conducted 
correlations.  This was done in an effort to determine the relationship between LBP, 
production parameters, and blood metabolites.  Cows were pooled for correlations in an 
effort to strengthen our results due to a small sample size.   
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Calculations 
Fat corrected milk (FCM) and solids corrected milk (SCM) were calculated as 
described by Tyrrell and Reid (1965) using the following equations: 3.5% FCM = (0.432 
x milk yield, kg) + (16.23 x milk fat yield, kg); SCM = (0.327 x milk yield, kg) + (12.95 
x milk fat yield, kg) + (7.2 x milk protein yield).  Energy balance was calculated using 
the following equations: EBAL = energy intake - energy output where energy intake = 
1.41 Mcal/kg x DMI (kg) for prefresh diet, 1.68 Mcal/kg x DMI for lactating diet and 
energy output = (NEM = 0.08 Mcal/kg x BW0.75) + [NEL = milk yield x (0.029 x fat % + 
0.0547 x protein % + 0.0395 x lactose %)].  Area under the curve (AUC) was calculated 
prior to analysis for all plasma metabolites. 
 
Statistical Analysis 
 Plasma LBP, NEFA, and BHBA concentrations were analyzed by repeated 
measures using the PROC MIXED procedure of SAS (2005) with an autoregressive 
covariance structure and day of lactation as the repeated effect. The model contained day 
of lactation, treatment, and day x treatment interaction.  Differences were considered 
significant when P < 0.05, unless otherwise stated.  Correlations were conducted using 
the PROC CORR procedure of SAS (2005) between the following parameters: peak LBP, 
peak Tr, body weight change, average milk yield (MY), slope MY, average solids-
corrected milk (SCM), average prepartum dry matter intake (Pre-DMI), average 
postpartum DMI (Post-DMI), slope Pre-DMI, slope Post-DMI, peak NEFA, peak BHBA, 
and average prepartum NEFA (Pre-NEFA). 
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Results 
Overall, “poor” transitioning cows had increased (21%, P = 0.04) circulating LBP 
compared to “good” transition cows and the difference was most pronounced (> 2 fold) 
on 3 DIM (Figure A-1.1).  Non-esterified fatty acid and BHBA levels were not different 
between “good” and “poor” transitioning cows (Figures A-1.2 and A-1.3).  Interestingly, 
winter calving cows had 52% (P = 0.05) greater LBP than summer calving cows and the 
difference was most pronounced (82%) at 3 DIM. 
 Peak LBP concentration was strongly correlated with peak Tr  (r = 0.47, P < 0.01) 
and milk yield (r = -0.39, P < 0.01) averaged over the first three weeks of lactation (Table 
A-1.1, Figures A-1.4 and A-1.5).  There were weak associations between peak LBP and 
body weight change (r = -0.28, P = 0.07), slope Pre-DMI (r = -0.24, P = 0.11), and Post-
DMI (r = -0.27, P = 0.08; Table A-1.1, Figures A-1.6 to A-1.8).  There was a relationship 
between peak Tr and Post-DMI (r = -0.30, P < 0.05; Table A-1.1, Figure A-1.9).  Peak Tr 
was weakly associated with MY (r = -0.25, P = 0.11; Table A-1.1, Figure A-1.10).   
There were strong positive correlations between MY and Pre-DMI (r = 0.32, P = 
< 0.05) as well as Post-DMI (r = 0.49, P < 0.01; Table A-1.1, Figures A-1.11 and A-
1.12).  As anticipated there was a positive relationship amongst slope MY and slope Post-
DMI (r = 0.33, P < 0.05; Table A-1.1, Figure A-1.13).  Similar to MY, SCM was 
positively correlated with Pre-DMI (r = 0.41, P < 0.01) and Post-DMI (r = 0.56, P < 0.01; 
Table A-1.1, Figures A-1.14 and A-1.15).  Pre-partum DMI was associated positively 
with Post-DMI (r = 0.65, P < 0.01; Table A-1.1, Figure A-1.16).  There were weak 
relationships between Pre-DMI and peak NEFA (r = -0.25, P = 0.11), as well as peak 
BHBA (r = -0.26, P = 0.10; Table A-1.1, Figure A-1.17 and A-1.18).  Interestingly, Post-
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DMI was correlated with slope Pre-DMI (r = 0.38, P < 0.01; Table A-1.1, Figure A-
1.19).  In concert with Pre-DMI, Post-DMI was negatively associated with peak NEFA (r 
= -0.28, P = 0.07) and peak BHBA (r = -0.51, P < 0.01; Table A-1.1, Figures A-1.20 and 
A-1.21).   
As expected, there was a strong positive relationship between peak NEFA and 
peak BHBA (r = 0.43, P < 0.01, Table A-1.1, Figure A-1.22).  While NEFA and BHBA 
concentration are often considered to be related to poor production, this was not the case 
with our analysis as MY and SCM were not correlated with peak NEFA or BHBA (Table 
A-1.1, Figures A-1.23 to A-1.26). 
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Table A-1.1: Correlations between blood metabolites and production parameters. 
 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
1 
P = 
-0.06 
0.71 
-0.25 
0.11 
0.08 
0.61 
-0.20 
0.23 
-0.22 
0.15 
-0.30 
<0.05 
-0.15 
0.34 
0.07 
0.67 
0.47 
<0.01 
0.32 
<0.05 
0.10 
0.52 
0.16 
0.30 
0.22 
0.16 
0.21 
0.17 
0.03 
0.86 
 2 
P = 
-0.10 
0.52 
-0.02 
0.91 
-0.09 
0.57 
-0.12 
0.44 
-0.10 
0.52 
-0.10 
0.53 
0.07 
0.68 
-0.28 
0.07 
-0.10 
0.51 
-0.20 
0.20 
-0.14 
0.38 
-0.23 
0.14 
-0.30 
<0.05 
-0.11 
0.53 
  3 
P = 
0.08 
0.59 
0.84 
<0.01 
0.32 
<0.05 
0.49 
<0.01 
0.09 
0.55 
0.03 
0.83 
-0.39 
<0.01 
-0.35 
<0.05 
-0.11 
0.50 
-0.27 
0.08 
0.09 
0.55 
0.01 
0.95 
0.15 
0.39 
   4 
P = 
0.10 
0.55 
0.03 
0.85 
0.15 
0.33 
0.13 
0.40 
0.33 
<0.05 
-0.04 
0.78 
-0.03 
0.86 
0.06 
0.71 
-0.11 
0.47 
0.02 
0.92 
0.11 
0.49 
-0.17 
0.31 
    5 
P = 
0.41 
<0.01 
0.56 
<0.01 
0.13 
0.42 
-0.13 
0.41 
-0.24 
0.13 
-0.21 
0.22 
0.06 
0.74 
-0.07 
0.66 
0.08 
0.64 
-0.05 
0.78 
0.21 
0.25 
     6 
P = 
0.65 
<0.01 
0.07 
0.66 
0.07 
0.68 
-0.13 
0.42 
-0.21 
0.18 
-0.26 
0.10 
-0.04 
0.79 
-0.25 
0.11 
0.02 
0.89 
-0.31 
0.06 
      7 
P = 
0.38 
<0.01 
0.21 
0.17 
-0.27 
0.08 
-0.19 
0.23 
-0.51 
<0.01 
-0.43 
<0.01 
-0.28 
0.07 
-0.15 
0.34 
-0.13 
0.44 
       8 
P = 
0.14 
0.36 
-0.24 
0.11 
0.00 
1.00 
-0.29 
0.06 
-0.18 
0.26 
-0.08 
0.62 
-0.15 
0.34 
0.11 
0.52 
        9 
P = 
-0.17 
0.29 
-0.18 
0.26 
-0.19 
0.22 
-0.21 
0.18 
-0.07 
0.68 
-0.07 
0.68 
-0.10 
0.54 
         10 
P = 
0.74 
<0.01 
0.21 
0.18 
0.37 
<0.01 
0.16 
0.31 
0.28 
0.07 
-0.03 
0.87 
          11 
P = 
0.18 
0.25 
0.21 
0.18 
0.17 
0.29 
0.17 
0.28 
-0.03 
0.88 
           12 
P = 
0.81 
<0.01 
0.43 
<0.01 
0.19 
0.23 
0.14 
0.40 
            13 
P = 
0.36 
<0.05 
0.45 
<0.01 
0.17 
0.31 
             14 
P = 
0.65 
<0.01 
0.31 
0.06 
1 = Peak rectal temperature 
2 = Body weight change d 1-21 
3 = Average milk yield d 1-21 
4 = Slope of milk yield d 1-21 
5 = Average SCM d 1-21 
6 = Average prepartum DMI 
7 = Average postpartum DMI 
8 = Slope of prepartum DMI 
9 = Slope of postpartum DMI 
10 = Peak LBP concentration 
11 = Max LBP area under curve 
12 = Peak BHBA 
13 = Max BHBA AUC 
14 = Peak NEFA 
15 = Max NEFA AUC 
16 = Prepartum NEFA 
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Figure A-1.1: Temporal pattern of LBP (ug/mL) in poor and good transition cows. 
Values represent LS means. 
Figure A-1.2: Temporal pattern of NEFA (µEq/L) in poor and good transition cows. 
Values represent LS means. 
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Figure A-1.3: Temporal pattern of BHBA (mg/dL) in poor and good transition cows. 
Values represent LS means. 
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Figure A-1.4: Relationship between peak LBP and peak rectal temperature (Tr) 
during the transition period.  
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Figure A-1.5: Relationship between peak LBP and milk yield during the transition 
period.  
Figure A-1.6: Relationship between peak LBP and body weight change during the 
transition period.  
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Figure A-1.7: Relationship between peak LBP and slope prepartum dry matter intake 
(DMI) during the transition period.  
Figure A-1.8: Relationship between peak LBP and slope postpartum dry matter intake 
(DMI) during the transition period.  
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Figure A-1.10: Relationship between p peak rectal temperature (Tr) and milk yield 
during the transition period.  
Figure A-1.9: Relationship between peak rectal temperature (Tr) and postpartum dry 
matter intake (DMI) during the transition period.  
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Figure A-1.12: Relationship between milk yield and postpartum dry matter intake 
(DMI) during the transition period.  
Figure A-1.11: Relationship between prepartum dry matter intake (DMI) and milk 
yield during the transition period.  
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Figure A-1.14: Relationship between prepartum dry matter intake (DMI) and solids-
corrected milk (SCM) during the transition period.  
Figure A-1.13: Relationship between slope milk yield and slope postpartum dry 
matter intake (DMI) during the transition period.  
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Figure A-1.16: Relationship between prepartum dry matter intake (DMI) and 
postpartum DMI during the transition period.  
Figure A-1.15: Relationship between solids-corrected milk (SCM) and postpartum 
dry matter intake (DMI) during the transition period.  
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Figure A-1.18: Relationship between prepartum dry matter intake (DMI)  and peak 
BHBA during the transition period.  
Figure A-1.17: Relationship between prepartum dry matter intake (DMI) and peak 
NEFA during the transition period.  
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Figure A-1.20: Relationship between postpartum dry matter intake (DMI) and peak 
NEFA during the transition period.  
Figure A-1.19: Relationship between slope prepartum dry matter intake (DMI) and 
postpartum DMI during the transition period.  
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Figure A-1.22: Relationship between peak NEFA and peak BHBA during the 
transition period.  
Figure A-1.21: Relationship between postpartum dry matter intake (DMI) and peak 
BHBA during the transition period.  
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Figure A-1.24: Relationship between milk yield and peak BHBA during the transition 
period.  
Figure A-1.23: Relationship between milk yield and peak NEFA during the transition 
period.  
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Figure A-1.25: Relationship between solids-corrected milk (SCM) and peak NEFA 
during the transition period.  
Figure A-1.26: Relationship between solids-corrected milk (SCM) and peak BHBA 
during the transition period.  
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APPENDIX 2 
DETERMINING THE EFFECTIVENESS OF PROTEASES ON PRODUCTION 
VARIABLES IN LACTATING HOLSTEIN COWS 
 
Abstract 
Ninety-six multiparous lactating Holstein dairy cows (2.7 ± 1.6 parity, 153.8 ± 
103.7 DIM, 40.3 ± 5.9 kg milk/d, 624 ± 62 kg BW) housed in a free stall barn were 
blocked by parity, days in milk and previous milk production and randomly assigned to a 
control TMR or a TMR containing a blend of supplemental protease enzymes (4 g/cow/d; 
Rumagentin™, Feed Sources LLC, Alta Loma, CA).  The TMR consisted primarily of 
corn silage, alfalfa hay, dried distiller grains, and concentrate and did not contain 
supplemental by-pass protein.  Cows were housed 24 to a pen (4 pens total) and thus pen 
was the experimental unit in a crossover design with two 21 d experimental periods.  Two 
pens received the supplement during period one and the other two pens received the 
control diet.  Pens then switched treatments during period 2 and there was a 7 d washout 
between periods.  The 7 d prior to period one were used as a covariate in the statistical 
analysis (repeated measures in the PROC MIXED procedure of SAS).  Daily pen milk 
yield and DMI were recorded and milk composition from all cows was determined on d 
15, 17, 19 and 21 of each period.  All data was condensed into weekly means.  There was 
no treatment effect on milk yield (37.6 kg/d), but supplemental enzyme-fed cows had less 
DMI (0.93 kg/d; P < 0.05) compared with controls and therefore tended (P = 0.06) to 
have improved (5.37%) feed efficiency (solids corrected milk/DMI).  Protease treatment 
had no effect on milk fat (3.53%) or milk protein (3.24%), but tended (P = 0.08) to 
increase milk lactose (4.73 vs. 4.76%).  Feeding supplemental enzymes tended (P = 0.10) 
to decrease milk urea nitrogen levels (15.1 vs. 14.6 mg/dl) but had no effect on milk 
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SCC.   In conclusion, supplementing a proprietary blend of protease enzymes improves 
feed efficiency and may enhance feed nitrogen utilization in lactating dairy cows. 
Materials And Methods 
Animals 
Ninety-six lactating Holstein cows (average of 2.7 ±1.6 parity, 153.8 ±103.7 days 
in milk, 40.3 ± 5.9 kg milk/d, 624 ± 62 kg BW) were housed in a free-stall barn (Iowa 
State University Dairy Farm) and assigned to one of two treatments.  Cows were milked 
twice daily (0800, 2000 h) and milk yields were recorded at each milking.  All cows were 
fed a total mixed ration (TMR) once daily (0730 h) and orts/weigh-backs were recorded 
prior to morning feeding (0630 h).  The diet primarily consisted of corn silage, alfalfa hay 
and concentrate pre-mix.  The TMR did not contain supplemental by-pass protein such as 
SoyPLUS®, Soy Best®, blood meal, etc. and was formulated by Dairy Health Services 
(Sanborn, IA) to meet or exceed the predicted requirements (NRC, 2001) of energy, 
protein, minerals and vitamins.  All procedures were reviewed and approved by the Iowa 
State University Institutional Animal Care and Use Committee (IACUC). 
 
Experimental Design 
Cows were split into four pens (24/pen) and fed diets with or without 
supplemental protease enzymes (Rumagentin™, Feed Sources LLC, Alta Loma, CA) 
during two 21 d periods in a continuous random cross over design.  There was a 7 d 
adaptation period to the control TMR without bypass protein.  During the first period 
(P1), half the cows (two pens) received the treatment diet (control TMR plus 
Rumagentin™) while the other half (two pens) received the control TMR.  After P1, 
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there was a 7-d washout period in which all cows (four pens) received the control TMR.  
During the second period (P2), treatment assignment switched; cows that received 
treatment TMR in P1 now received the control TMR and vice versa.  The granular form 
of enzymes was mixed with a ground-corn grain carrier (Mid-State Milling State, Center, 
IA).  Ground corn was added to TMR (at mixing) at a rate of 0.91 kg/cow/d and 
contained either enzyme or no treatment (plain ground corn) to provide product at a level 
of 4 g/head/d.  
 
Schematic of Experimental Design 
 
Group 1 
7 d 21 d 7 d 21 d 7 d 
Adaptation Control Washout RumagentinTM Washout 
 
 
  
  
 
 
 
 
 
  
Group 2 
7 d 21 d 7 d 21 d 7 d 
Adaptation RumagentinTM Washout Control Washout 
Cross-over design 
n= 96 cows 
4 pens of 24 cows 
Group 1 = 2 pens 
Group 2 = 2 pens 
Parameters: 
Daily milk yield 
Daily pen feed intake 
Milk composition 
Blood urea nitrogen 
Experiment: 63 days total 
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Milk and Blood Sampling 
Milk samples from each cow were collected during the a.m. milking on d 15, 17, 
19 and 21 relative to treatment initiation during both periods.  Samples from each 
collection were stored at 4°C in vials containing a preservative (bronopol tablet; D&F 
Control System, San Ramon, CA) until analysis.  Samples were analyzed by Dairy Lab 
Services (Dubuque, IA) using AOAC approved infrared analysis equipment and 
procedures for milk components.   
Calculations 
Fat corrected milk (FCM) and solids corrected milk yield (SCM) were calculated 
as described by NRC (2001) and Tyrrell and Reid (1965) respectively: 4.0 % FCM, kg/d 
= 0.4 × milk yield (kg) + 15 (milk fat (kg) / 100) × milk yield (kg) 4.0 % SCM, kg/d  = 
12.24 × milk fat yield (kg) + 7.10 × milk protein yield (kg) + 6.35 × milk lactose yield 
(kg) − 0.0345 × milk yield (kg).  Feed efficiency was calculated using solids corrected 
milk yield/dry matter intake.  Blood samples were obtained via coccygeal venipuncture 
during both periods on d -1 and 21 of each period using heparinized vacutainer tubes 
(Becton Dickinson, Franklin Lakes, NJ).  Plasma was harvested following centrifugation 
at 2100 x g for 15 min, and subsequently stored at -20°C until analysis. 
 
Statistical Analysis 
The effects of treatment on pen feed intake, feed efficiency, milk yield, and milk 
components were analyzed using the PROC MIXED procedure of SAS, with week as a 
repeated measure and pen (treatment) as the random statement.  Pen was the experimental 
unit on all analyzed data.  Pre-supplementation milk yield values (d -7 to -1) were used as 
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a covariate to adjust all data, except BUN, which was adjusted using pre-supplementation 
BUN values as the covariate.  Results are reported as least squares means and in all cases, 
differences among means were declared as significant at P < 0.05, whereas trends were 
discussed at P < 0.10, unless stated otherwise.    
 
Results 
Feed Intake and Efficiency  
Production variables are presented in Table A-2.1.  Protease-fed cows had 
decreased dry matter intake (DMI; 0.93 kg/d; P < 0.05) compared to control cows (Figure 
A-2.1).  There was a tendency (Figure A-2.2, P = 0.06) for an improved feed efficiency 
(solids corrected milk/ dry matter intake) of 5.37% for protease-fed compared to control 
cows.  However, gross feed efficiency (MY/DMI) did not differ among treatments 
(Figure A-2.3, P = 0.14). 
 
Milk Production and Components 
Milk production and milk composition parameters are presented in Table A-2.1, 
and graphically shown in Figures A-2.4 to A-2.13.  Production parameters did not differ 
(P > 0.05) among treatments: milk yield (37.6 vs. 37.8 kg), 4.0% fat corrected milk (31.2 
vs. 30.9 kg), solids corrected milk (34.2 vs. 33.9 kg), milk fat (3.5 vs. 3.6 %), milk 
protein (3.2 vs. 3.3 %), and somatic cell count (303 vs. 389 1000/mL).  However, 
protease-fed cows exhibited a decreased blood urea nitrogen concentration (10.02%; P < 
0.05) and tended to have increased milk lactose (0.06%; P = 0.08), and decreased milk 
102 
!
102 
urea nitrogen levels (3.4%; P = 0.10) and somatic cell score (3.7%; P = 0.10) compared 
to control cows. 
 
Conclusions 
Supplementing a proprietary blend of protease enzymes (RumagentinTM) had no overall 
effect on milk yield, but decreased DMI, showing a tendency for improved feed 
efficiency. Protease-fed cows had a significant decrease in blood urea nitrogen and 
tended to have decreased milk urea nitrogen, which may represent enhanced nitrogen 
utilization.  In addition, a tendency for increased milk lactose and decreased somatic cell 
score were observed in cows supplemented with RumagentinTM.  
 
Table A-2.1: Effects of Rumagentin™ on dry matter intake, feed efficiency, milk yield, 
and milk components. 
Variable Control RumagentinTM      SEM P 
DMI, kg1 24.3 23.4 0.1   < 0.01 
Feed efficiency2  1.4 1.5 < 0.1 0.06 
Gross feed efficiency3 1.5 1.6 < 0.1 0.14 
Milk yield, kg 37.6 37.8 0.6 0.82 
4.0% Fat-corrected milk, kg 30.9 31.2 0.9 0.81 
4.0% SCM, kg 33.9 34.2 0.5 0.67 
Fat, % 3.6 3.5 0.1 0.80 
Protein, % 3.3 3.2 < 0.1 0.47 
Lactose, % 4.7 4.8 < 0.1 0.08 
Total solids, % 12.0 12.0 0.1 0.98 
SCC4, 1000/mL 389 303 45 0.28 
SCS5 2.2 2.1 < 0.1 0.10 
MUN6, mg/dL 15.1 14.6 0.2 0.10 
BUN7, mg/dL 12.8 11.5 0.4 < 0.01 
1Dry matter intake 
2Solids corrected milk (SCM) / DMI 
3Milk yield / DMI 
4Milk somatic cell count 
5Milk somatic cell score = log of SCC 
6Milk urea nitrogen 
7Blood urea nitrogen 
a,b Indicates P < 0.05 
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Figure A-2.1:  Effect of RumagentinTM on weekly dry mater intake in lactating Holstein 
cows.  Values are presented as means; SEM averaged 0.23 kg/wk. !!!
!
Figure A-2.2: Effect of RumagentinTM on weekly feed efficiency (SCM/DMI) in 
lactating Holstein cows.  Values are presented as means; SEM averaged 0.03 kg/wk. 
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Figure A-2.3: Effects of RumagentinTM on gross weekly feed efficiency (milk 
yield/DMI) in lactating Holstein cows. Values are means, SEM averaged 0.03. 
 
 !
Figure A-2.4: Effects of RumagentinTM on weekly milk yield in lactating Holstein cows. 
Values are means; SEM averaged 0.61 kg/wk.!
0 
1 
2 
3 
1 2 3 
G
ro
ss
 fe
ed
 e
ffi
ci
en
cy
 
Week 
Control  Rumagentin™ 
35 
36 
37 
38 
39 
1 2 3 
M
ilk
 y
ie
ld
, k
g/
w
k 
Week 
Control  Rumagentin™ 
105 
!
105 
Figure A-2.5: Effects of RumagentinTM on weekly 4.0% fat corrected milk yield in 
lactating Holstein cows. Values are means; SEM averaged 0.87 kg/wk. !!!
!
Figure A-2.6: Effects of RumagentinTM on weekly 4.0% solids corrected milk yield in 
lactating Holstein cows. Values are means; SEM averaged 0.49 kg/wk.!!
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Figure A-2.7: Effects of RumagentinTM on milk fat content in lactating Holstein cows. 
Data represent sampled days, values are means; SEM averaged 0.09%.!!!!
Figure A-2.8: Effects of RumagentinTM on milk protein content in lactating Holstein 
cows. Data represent sampled days, values are means; SEM averaged 0.06%.!!
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Figure A-2.9: Effects of RumagentinTM on milk lactose content in lactating Holstein 
cows. Data represent sampled days, values are means; SEM averaged 0.01%.!!!!
Figure A-2.10: Effects of RumagentinTM on milk total solids content in lactating 
Holstein cows. Data represent sampled days, values are means; SEM averaged 12%. !!
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Figure A-2.11: Effects of RumagentinTM on milk somatic cell count in lactating Holstein 
cows. Data represent sampled days, values are means; SEM averaged 67.!!!!
 
Figure A-2.12: Effects of RumagentinTM on milk somatic cell score in lactating Holstein 
cows. Data represent sampled days, values are means; SEM averaged 0.03.!!!!
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Figure A-2.13: Effects of RumagentinTM on milk urea nitrogen in lactating Holstein 
cows.!Data represent sampled days, values are means; SEM averaged 0.22 mg/dl.!!!!
Figure A-2.14: Effects of RumagentinTM on blood urea nitrogen in lactating Holstein 
cows.!Data represent sampled day, values are means; SEM averaged 0.40 mg/dl. !
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